<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9607835</journal-id>
<journal-id journal-id-type="pubmed-jr-id">20545</journal-id>
<journal-id journal-id-type="nlm-ta">Mol Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Molecular psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">1359-4184</issn>
<issn pub-type="epub">1476-5578</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28194001</article-id>
<article-id pub-id-type="pmc">5555837</article-id>
<article-id pub-id-type="doi">10.1038/mp.2017.9</article-id>
<article-id pub-id-type="manuscript">NIHMS839087</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Enhancing VTA Ca<sub>v</sub>1.3 L-type Ca<sup>2+</sup> channel activity promotes cocaine and mood - related behaviors via overlapping AMPA receptor mechanisms in the nucleus accumbens</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Martínez-Rivera</surname>
<given-names>Arlene</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hao</surname>
<given-names>Jin</given-names>
</name>
<degrees>BS</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tropea</surname>
<given-names>Thomas F.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Giordano</surname>
<given-names>Thomas P.</given-names>
</name>
<degrees>BS</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kosovsky</surname>
<given-names>Maria</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rice</surname>
<given-names>Richard C.</given-names>
</name>
<degrees>BS</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Amy</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huganir</surname>
<given-names>Richard L.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Striessnig</surname>
<given-names>Joerg</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Addy</surname>
<given-names>Nii A.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Han</surname>
<given-names>Shizhong</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A7">7</xref>
<xref ref-type="author-notes" rid="FN2">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rajadhyaksha</surname>
<given-names>Anjali M.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN1">†</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Dept. of Pediatrics, Division of Pediatric Neurology, Weill Cornell Medicine, New York, NY, USA</aff>
<aff id="A2">
<label>2</label>Feil Family Brain and Mind Research Institute, Weill Cornell Medical College, New York, NY, USA</aff>
<aff id="A3">
<label>3</label>Department of Molecular Physiology and Biophysics, University of Iowa, Iowa City, IA, USA</aff>
<aff id="A4">
<label>4</label>Department of Solomon H. Snyder Department of Neuroscience, Kavli Neuroscience Discovery Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA</aff>
<aff id="A5">
<label>5</label>Pharmacology and Toxicology, University of Innsbruck, Innsbruck, Austria; Center for Molecular Biosciences, University of Innsbruck, Innsbruck, Austria</aff>
<aff id="A6">
<label>6</label>Department of Psychiatry and Department of Cellular and Molecular Physiology, Yale School of Medicine, New Haven, CT, USA; Interdepartmental Neuroscience Program, Yale Graduate School of Arts and Science, New Haven, CT, USA</aff>
<aff id="A7">
<label>7</label>Department of Psychiatry, University of Iowa Carver College of Medicine, Iowa City, IA, USA</aff>
<author-notes>
<corresp id="FN1"><label>†</label>Corresponding author: Anjali Rajadhyaksha, Pediatric Neurology, Pediatrics, Weill Cornell Medicine, 1300 York Avenue, Box 91, New York, NY 10065, USA, Tel: 212.746.5999, <email>amr2011@med.cornell.edu</email></corresp>
<corresp id="FN2"><label>*</label>Corresponding author genetics: Shizhong Han, Department of Psychiatry - 22G GH, University of Iowa, Iowa City, IA, 52242, Phone: 319-353-8773, <email>shizhong-han@uiowa.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>31</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>14</day>
<month>2</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>30</day>
<month>11</month>
<year>2017</year>
</pub-date>
<volume>22</volume>
<issue>12</issue>
<fpage>1735</fpage>
<lpage>1745</lpage>
<!--elocation-id from pubmed: 10.1038/mp.2017.9-->
<permissions>
<license>
<license-p>Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:
<uri xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms" xlink:type="simple">http://www.nature.com/authors/editorial_policies/license.html#terms</uri></license-p>
</license>
</permissions>
<abstract>
<p id="P1">Genetic factors significantly influence susceptibility for substance abuse and mood disorders. Rodent studies have begun to elucidate a role of Ca<sub>v</sub>1.3 L-type Ca<sup>2+</sup> channels in neuropsychiatric-related behaviors, such as addictive and depressive-like behaviors. Human studies have also linked the <italic>CACNA1D</italic> gene, which codes for the Ca<sub>v</sub>1.3 protein, with bipolar disorder (BD). However, the neurocircuitry and the molecular mechanisms underlying the role of Ca<sub>v</sub>1.3 in neuropsychiatric phenotypes are not well established. In the present study, we directly manipulated Ca<sub>v</sub>1.3 channels in Ca<sub>v</sub>1.2 dihydropyridine (DHP) insensitive mutant mice and found that VTA Ca<sub>v</sub>1.3 channels mediate cocaine-related and depressive-like behavior through a common nucleus accumbens (NAc) shell calcium permeable AMPA receptor (CP-AMPAR) mechanism that requires GluA1 phosphorylation at S831. Selective activation of VTA Ca<sub>v</sub>1.3 with (±)-BayK-8644 (BayK) enhanced cocaine conditioned place preference (CPP) and cocaine psychomotor activity while inducing depressive-like behavior, an effect not observed in S831A phospho-mutant mice. Infusion of the CP-AMPAR-specific blocker Naspm into the NAc shell reversed the cocaine and depressive-like phenotypes. In addition, activation of VTA Ca<sub>v</sub>1.3 channels resulted in social behavioral deficits. In contrast to the cocaine- and depression-related phenotypes, GluA1/A2 AMPARs in the NAc core mediated social deficits, independent of S831-GluA1 phosphorylation. Using a candidate gene analysis approach, we also identified single nucleotide polymorphisms in the <italic>CACNA1D</italic> gene associated with cocaine dependence (CD) in human subjects. Together, our findings reveal novel, overlapping mechanisms through which VTA Ca<sub>v</sub>1.3 mediates cocaine-related, depressive-like and social phenotypes suggesting that Ca<sub>v</sub>1.3 may serve as a target for the treatment of neuropsychiatric symptoms.</p>
</abstract>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>INTRODUCTION</title>
<p id="P2">Altered reward brain circuitry and reward processing is associated with multiple psychiatric disorders<sup><xref ref-type="bibr" rid="R1">1</xref></sup>. In particular, substance abuse disorders are often co-morbid with mood disorders particularly bipolar disorder (BD)<sup><xref ref-type="bibr" rid="R2">2</xref></sup> and major depressive disorder<sup><xref ref-type="bibr" rid="R3">3</xref></sup>. Common genetic risk factors<sup><xref ref-type="bibr" rid="R4">4</xref>–<xref ref-type="bibr" rid="R5">5</xref></sup>, overlapping neurocircuitry<sup><xref ref-type="bibr" rid="R6">6</xref>, <xref ref-type="bibr" rid="R7">7</xref></sup> and convergence of cellular and molecular mechanisms<sup><xref ref-type="bibr" rid="R7">7</xref>, <xref ref-type="bibr" rid="R8">8</xref></sup> have been suggested to underlie this co-morbidity. In particular, recent findings provide evidence that human variants in the <italic>CACNA1D</italic> gene, which codes for the Ca<sub>v</sub>1.3 subunit of L-type Ca<sup>2+</sup> channels (LTCCs), can confer risk for the development of neuropsychiatric disorders<sup><xref ref-type="bibr" rid="R9">9</xref>, <xref ref-type="bibr" rid="R10">10</xref></sup> including BD<sup><xref ref-type="bibr" rid="R11">11</xref>, <xref ref-type="bibr" rid="R12">12</xref></sup>. Emerging data on impact of human mutations on Ca<sub>v</sub>1.3 physiology<sup><xref ref-type="bibr" rid="R13">13</xref></sup> and from animal studies<sup><xref ref-type="bibr" rid="R14">14</xref>–<xref ref-type="bibr" rid="R16">16</xref></sup> suggests that enhanced Ca<sub>v</sub>1.3 activity may contribute to neuropsychiatric disorders. This is in agreement with a crucial role of this channel in neuronal signaling<sup><xref ref-type="bibr" rid="R10">10</xref>, <xref ref-type="bibr" rid="R17">17</xref>, <xref ref-type="bibr" rid="R18">18</xref></sup> underlying drug taking and emotional behaviors. However, as for other risk genes, the precise Ca<sub>v</sub>1.3–dependent mechanisms and neurocircuits that contribute to the neurobiology of neuropsychiatric-related behavioral phenotypes remain unknown.</p>
<p id="P3">The VTA-NAc pathway plays a central role in mediating the effects of cocaine<sup><xref ref-type="bibr" rid="R19">19</xref></sup>, depressive-like<sup><xref ref-type="bibr" rid="R20">20</xref>, <xref ref-type="bibr" rid="R21">21</xref></sup> and social behavior<sup><xref ref-type="bibr" rid="R22">22</xref></sup>. LTCCs in the VTA regulate DA burst firing activity<sup><xref ref-type="bibr" rid="R23">23</xref>, <xref ref-type="bibr" rid="R24">24</xref></sup>, a property known to mediate reward behaviors<sup><xref ref-type="bibr" rid="R25">25</xref></sup>, depressive-like behaviors<sup><xref ref-type="bibr" rid="R26">26</xref></sup>, social interaction<sup><xref ref-type="bibr" rid="R22">22</xref></sup> and responses to stress<sup><xref ref-type="bibr" rid="R20">20</xref>, <xref ref-type="bibr" rid="R21">21</xref></sup>. We and others have shown that Ca<sub>v</sub>1.3 that is expressed in VTA dopamine neurons<sup><xref ref-type="bibr" rid="R27">27</xref>, <xref ref-type="bibr" rid="R28">28</xref></sup> is required for the short- and the long-term effects of cocaine<sup><xref ref-type="bibr" rid="R14">14</xref>–<xref ref-type="bibr" rid="R16">16</xref></sup>. Acute activation of Ca<sub>v</sub>1.3 by systemic injection of BayK, has also been shown to induce depressive-like behavior<sup><xref ref-type="bibr" rid="R28">28</xref></sup>. Collectively, these findings suggest a role of Ca<sub>v</sub>1.3 channels in addictive behavior and mood disorders.</p>
<p id="P4">Emerging evidence is establishing neuropsychiatric disorders as synaptic diseases. Several studies have reported enhanced glutamatergic AMPAR transmission, in particular increase in synaptic GluA2-lacking Ca<sup>2+</sup> permeable AMPARs (CP-AMPARs herein) in medium spiny neurons of the NAc, as a key mechanism underlying cocaine-induced long-lasting behavioral plasticity<sup><xref ref-type="bibr" rid="R29">29</xref>–<xref ref-type="bibr" rid="R35">35</xref></sup>. Enhanced AMPAR transmission in the NAc has also been reported to drive depressive-like and social behavior<sup><xref ref-type="bibr" rid="R36">36</xref></sup>, suggesting that modulation of AMPAR transmission could represent one common mechanism linking addiction and mood disorders.</p>
<p id="P5">Given the evidence of enhanced VTA-NAc activity in drug taking and mood-related behaviors<sup><xref ref-type="bibr" rid="R19">19</xref>, <xref ref-type="bibr" rid="R21">21</xref>, <xref ref-type="bibr" rid="R22">22</xref></sup>, Ca<sub>v</sub>1.3 channel properties in VTA dopamine cells<sup><xref ref-type="bibr" rid="R24">24</xref></sup> and Ca<sub>v</sub>1.3 gain of function mutations in neurological disease<sup><xref ref-type="bibr" rid="R10">10</xref></sup>, we hypothesized that enhanced activity of VTA Ca<sub>v</sub>1.3 channels would drive cocaine-related behaviors and mood-related phenotypes such as depressive-like, anxiety-like and social behavior. To this end, we utilized Ca<sub>v</sub>1.2 DHP insensitive (Ca<sub>v</sub>1.2 DHP<sup>−/−</sup>) mutant mice. A single point mutation in the Ca<sub>v</sub>1.2 α1-subunit of these mice does not affect Ca<sub>v</sub>1.2 function and expression, but renders them insensitive to (±)-BayK-8644 and strongly reduces their sensitivity to DHP Ca<sup>2+</sup> channel blockers, such as nifedipine<sup><xref ref-type="bibr" rid="R28">28</xref>, <xref ref-type="bibr" rid="R37">37</xref></sup>. As successfully demonstrated in previous studies<sup><xref ref-type="bibr" rid="R15">15</xref>, <xref ref-type="bibr" rid="R38">38</xref></sup> this allows us to specifically pharmacologically manipulate Ca<sub>v</sub>1.3 channels in the VTA in these mice. Subsequently, we pharmacologically assessed AMPARs in the NAc and utilized AMPAR subunit GluA1 phosphorylation deficient mutant mice to assess the necessity of GluA1 phosphorylation in cocaine and mood-related behaviors. Finally, we tested genetic variants within and around <italic>CACNA1D</italic> for association with cocaine dependence (CD; as defined by DSM-IV criteria) using a genome-wide association dataset.</p>
</sec>
<sec id="S2" sec-type="materials|methods">
<title>MATERIALS AND METHODS</title>
<p id="P6">Detailed methods are provided in <xref ref-type="supplementary-material" rid="SD12">Supplementary Information</xref>.</p>
<sec id="S3">
<title>Animals</title>
<p id="P7">All experimental procedures were conducted in accordance with Weill Cornell Medicine IACUC guidelines. Male C57BL/6 (Jackson Laboratories, Bar Harbor, Maine), Ca<sub>v</sub>1.3 knockout (KO)<sup><xref ref-type="bibr" rid="R39">39</xref></sup>, Ca<sub>v</sub>1.2 DHP-insensitive<sup><xref ref-type="bibr" rid="R28">28</xref></sup> and GluA1 S831A phospho-mutant mice<sup><xref ref-type="bibr" rid="R40">40</xref></sup> all on C57BL/6J background, were 8–10 weeks old at the start of the experiments. Animals were maintained on a 12-hr light/dark cycle (from 7A.M. to 7P.M.).</p>
</sec>
<sec id="S4">
<title>Drugs and antibodies</title>
<p id="P8">Cocaine HCl, nifedipine (Nif), (±)-BayK-8644 (BayK), and Naspm were obtained from Sigma (St. Louis, MO). NBQX was obtained from Tocris Bioscience (Minneapolis, MN). Nif and BayK were dissolved in 0.9% saline containing 1.5% DMSO and 1.5% Tween80. Naspm and NBQX were dissolved in 0.9% saline. Antibodies listed in <xref ref-type="supplementary-material" rid="SD2">Supplementary Table 1</xref>.</p>
</sec>
<sec id="S5">
<title>Subcellular fractionation</title>
<p id="P9">Mice were euthanized by rapid decapitation and bilateral VTA (18-gauge stainless-steel stylet), NAc (18-gauge stainless-steel stylet) or PFC (17-gauge stainless-steel stylet) tissue was obtained. Total protein lysates were isolated as previously described<sup><xref ref-type="bibr" rid="R41">41</xref></sup>. For postsynaptic density (PSD) fractions, subcellular fractionation was performed as published before<sup><xref ref-type="bibr" rid="R42">42</xref></sup>.</p>
</sec>
<sec id="S6">
<title>Coimmunoprecipiation assay</title>
<p id="P10">Crude membrane fractions were generated from bilateral VTA tissue pooled from four mice. Co-imunoprecipitation was performed as published in Calin-Jageman et al. (2007)<sup><xref ref-type="bibr" rid="R43">43</xref></sup>.</p>
</sec>
<sec id="S7">
<title>Immunoblot Analysis</title>
<p id="P11">Immunoblotting and quantitation was performed as previously described in Schierberl et al. (2011)<sup><xref ref-type="bibr" rid="R15">15</xref></sup>. Tubulin was used as a loading control for all PSD immunoblots.</p>
</sec>
<sec id="S8">
<title>Guide cannula surgery</title>
<p id="P12">For delivery of pharmacological drugs into the VTA or the NAc, guide cannula were implanted bilaterally in adult male mice as previously published<sup><xref ref-type="bibr" rid="R15">15</xref></sup>. Coordinates and drug concentrations are included in <xref ref-type="supplementary-material" rid="SD3">Supplementary Table 2</xref>.</p>
</sec>
<sec id="S9">
<title>Delivery of viral vectors into the VTA or NAc</title>
<p id="P13">AAV stereotaxic surgery and delivery of the AAV (<xref ref-type="supplementary-material" rid="SD4">Supplementary Table 3</xref>) was performed as previously published<sup><xref ref-type="bibr" rid="R15">15</xref></sup>.</p>
</sec>
<sec id="S10">
<title>Cocaine conditioned place preference test</title>
<p id="P14">A three-chamber place preference protocol (Med Associates Inc., St. Albans, VT, USA) was used as previously described in Tropea et al. 2008<sup><xref ref-type="bibr" rid="R44">44</xref></sup>. On Day1 mice were allowed to freely explore all three chambers (20 min). On Day 2–4 (conditioning sessions), a biased procedure was used wherein mice were paired with cocaine (10 mg/kg, i.p.) for 20 min in the morning on the less preferred side, and paired with saline for 20 min in the afternoon on the opposite side. On Day 5 (WD1) mice were allow to freely explore the CPP box for 20 min and time spent in cocaine-paired side (sec) was recorded. For some experiments, mice were re-tested on day 34 (WD30).</p>
</sec>
<sec id="S11">
<title>Sucrose Preference Test (SPT)</title>
<p id="P15">Individually housed mice were habituated to two 50 ml bottles, one containing water and the other 1% sucrose for one day. For two days, body weight and mass of water and sucrose consumed was monitored. Results are presented as sucrose preference calculated as (sucrose consumed (g)/(sucrose consumed (g) + water consumed (g)))*100.</p>
</sec>
<sec id="S12">
<title>Forced Swim Test (FST)</title>
<p id="P16">Mice were placed in a 2 liter beaker filled with 1600 ml of water between 25–26°C for 10 minutes. Immobility time was scored using the computer-assisted software ButtonBox v5.1 (Behavioral Research Solutions, Dallas Texas).</p>
</sec>
<sec id="S13">
<title>Three-Chambered Social Interaction test</title>
<p id="P17">Social approach was performed as published in Inan et al. 2016<sup><xref ref-type="bibr" rid="R45">45</xref></sup>. Following a 10 min habituation, mice were allowed to freely explore the apparatus containing an inanimate object and a stranger mouse and time spent within a predefined contact zone was recorded.</p>
</sec>
<sec id="S14">
<title>Elevated Plus Maze (EPM) test</title>
<p id="P18">EPM test was performed as previously reported by Lee et al. (2012)<sup><xref ref-type="bibr" rid="R46">46</xref></sup>. Data is reported as the percent of time spent in the open arms which was calculated as: (time in open arms (s)/total time (s))*100.</p>
</sec>
<sec id="S15">
<title>Human Genetics</title>
<p id="P19">To examine whether genetic variants within and around <italic>CACNA1D</italic> contribute to CD susceptibility in humans, we conducted a candidate gene association analysis for <italic>CACNA1D</italic> with CD using a genome-wide association study (GWAS) data set from the Study of Addiction: Genetics and Environment (SAGE), previously described in detail<sup><xref ref-type="bibr" rid="R47">47</xref></sup> and as detailed in the <xref ref-type="supplementary-material" rid="SD13">Supplementary Methods</xref>.</p>
</sec>
<sec id="S16">
<title>Statistical Analyses</title>
<p id="P20">All statistical analyses were conducted using Graphpad Prism 6 (GraphPad Software, La Jolla, CA). A two-tailed unpaired t-test was performed after confirmation of normal distribution of the data using the Shapiro-Wilk test. If data were not normally distributed, the Mann Whitney nonparametric test was performed as indicated in the text. For experiments with four groups, a two-way analyses of variance (ANOVA) for main effect of experimental variables was performed followed by the Bonferroni-Dunn <italic>post hoc</italic> test. Statistical tests are specified in the results or in the figure legends and data were considered to be statistically significant for values of <italic>P</italic> ≤ 0.05.</p>
</sec>
</sec>
<sec id="S17" sec-type="results">
<title>RESULTS</title>
<sec id="S18">
<title>Ca<sub>v</sub>1.3 forms functional channels at the VTA postsynaptic density</title>
<p id="P21">Ca<sub>v</sub>1.3 mRNA is highly expressed in rat VTA dopamine neurons<sup><xref ref-type="bibr" rid="R27">27</xref></sup>. Ca<sub>v</sub>1.3 protein is enriched in PSD fractions prepared from mouse VTA (<xref ref-type="fig" rid="F1">Figure 1a</xref>) and associates with the PDZ scaffolding protein PSD-95 and Shank3 (<xref ref-type="fig" rid="F1">Figure 1b, c</xref>). This interaction through its C-terminal class I PDZ binding domain (ITTL) is necessary for activity-dependent signaling in VTA slices, as revealed by lack of phosphorylation of the transcription factor CREB, a downstream target of Ca<sub>v</sub>1.3 channels<sup><xref ref-type="bibr" rid="R38">38</xref></sup>, in the presence of a dominant-negative peptide to ITTL (<xref ref-type="fig" rid="F1">Figure 1d</xref>). Thus, Ca<sub>v</sub>1.3 protein is present in functional signaling complexes in the mouse VTA.</p>
</sec>
<sec id="S19">
<title>VTA Ca<sub>v</sub>1.3 channel activation enhances cocaine-related behaviors</title>
<p id="P22">We have reported that blocking VTA Ca<sub>v</sub>1.3 channels with nifedipine blocks cocaine psychomotor sensitization<sup><xref ref-type="bibr" rid="R15">15</xref></sup>. Similarly, VTA nifedipine infusions in Ca<sub>v</sub>1.2 DHP<sup>−/−</sup> mice (<xref ref-type="fig" rid="F1">Figure 1e–f</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 1a</xref>) attenuated cocaine CPP, a measure of cocaine reward, twenty-four hours (WD1 herein) and 30 days (WD30 herein) after the last conditioning session (<xref ref-type="fig" rid="F1">Figure 1g</xref>). These mice also exhibited a lower cocaine-induced locomotor response (<xref ref-type="fig" rid="F1">Figure 1h</xref>), an effect replicated by VTA Ca<sub>v</sub>1.3shRNA-mediated Ca<sub>v</sub>1.3 knockdown (<xref ref-type="fig" rid="F1">Figure 1e, i–k</xref>). Of note, blocking (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 1b–d</xref>) or knocking down (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 1e–f</xref>) Ca<sub>v</sub>1.3 channels in the NAc had no effect on cocaine CPP.</p>
<p id="P23">To test if pharmacological activation of VTA Ca<sub>v</sub>1.3 channels enhanced cocaine-induced behaviors, Ca<sub>v</sub>1.2 DHP<sup>−/−</sup> mice received BayK infusions into the VTA (<xref ref-type="fig" rid="F1">Figure 1e, 1l</xref>), which further increased cocaine CPP (<xref ref-type="fig" rid="F1">Figure 1m</xref>) and cocaine-induced locomotor activity (<xref ref-type="fig" rid="F1">Figure 1n</xref>). Thus, cocaine-induced behaviors require VTA Ca<sub>v</sub>1.3 channels and VTA Ca<sub>v</sub>1.3 activation is capable of enhancing cocaine-mediated behaviors.</p>
</sec>
<sec id="S20">
<title>VTA Ca<sub>v</sub>1.3 channels are necessary for a GluA1 S831 phosphorylation-dependent increase in CP-AMPARs in the NAc shell</title>
<p id="P24">Increase in synaptic AMPAR transmission by redistribution of AMPAR subunits, GluA1 and GluA2 has been observed in the NAc following cocaine treatment and behaviors<sup><xref ref-type="bibr" rid="R33">33</xref></sup>. We measured levels of GluA1 and GluA2 in PSD fractions, indicative of synaptic levels, from NAc (shell and core combined) at WD1 and WD30 and role of VTA Ca<sub>v</sub>1.3 channels, therein (<xref ref-type="fig" rid="F2">Figure 2a</xref>). Cocaine CPP increased PSD GluA1 but not GluA2 levels in the NAc at WD30 (<xref ref-type="fig" rid="F2">Figure 2b</xref>) but not WD1 (<xref ref-type="supplementary-material" rid="SD6">Supplementary Figure 2c–d</xref>). The GluA1 increase was blocked in VTA nifedipine (<xref ref-type="fig" rid="F2">Figure 2b</xref>) and VTA Ca<sub>v</sub>1.3shRNA (<xref ref-type="supplementary-material" rid="SD6">Supplementary Figure 2a</xref>) pretreated mice. Cocaine had no effect on PSD GluA1 levels in the PFC, a region that also receives VTA projections (<xref ref-type="fig" rid="F2">Figure 2a, c</xref> and <xref ref-type="supplementary-material" rid="SD6">Supplementary Figure 2b</xref>).</p>
<p id="P25">The increase in GluA1 and not GluA2 at WD30 suggested the possibility of accumulation of GluA2-lacking CP-AMPARs. Thus, we infused the CP-AMPAR blocker, Naspm into the NAc shell 20 min before the WD30 CPP test (<xref ref-type="fig" rid="F2">Figure 2d, e</xref>) and observed an attenuation of cocaine CPP (<xref ref-type="fig" rid="F2">Figure 2f</xref>). Similarly, Naspm in the NAc shell blocked the expression of cocaine psychomotor sensitization on WD30 (<xref ref-type="fig" rid="F2">Figure 2g</xref>). Thus, cocaine results in upregulation of CP-AMPARs within the NAc shell following extended withdrawal, an adaptation that requires activation of VTA Ca<sub>v</sub>1.3 channels.</p>
<p id="P26">Since GluA1 synaptic function and trafficking is regulated by phosphorylation at Ser 831 (S831) via CaMKinase IIα (CaMKIIα), and Ser 845 (S845) via Protein Kinase A (PKA)<sup><xref ref-type="bibr" rid="R48">48</xref></sup>, we measured levels of these proteins in NAc PSD fractions at WD30. Cocaine treated mice had higher CaMKIIα, P-CaMKIIα and P-S831 GluA1, an effect that was absent in VTA nifedipine pretreated mice (<xref ref-type="fig" rid="F2">Figure 2h</xref>). No differences in levels of S845 or PKA were seen (<xref ref-type="fig" rid="F2">Figure 2h</xref>). To test the causal role of S831-GluA1 phosphorylation in inducing the cocaine behaviors, we utilized S831 phosphorylation deficient mutant mice (S831A)<sup><xref ref-type="bibr" rid="R40">40</xref></sup>. WT and S831A mice exhibited similar levels of cocaine preference at WD1 (<xref ref-type="fig" rid="F2">Figure 2i</xref>) and similar psychomotor sensitization on cocaine Day 5 (<xref ref-type="fig" rid="F2">Figure 2j</xref>). However, at WD30, S831A mice had a blunted CPP response (<xref ref-type="fig" rid="F2">Figure 2i</xref>) and a blunted psychomotor response (<xref ref-type="fig" rid="F2">Figure 2j</xref>). Collectively, the above experiments demonstrated that activation of VTA Ca<sub>v</sub>1.3 channels are necessary for mediating the protracted accumulation of CP-AMPARs in the NAc shell via upregulation of CaMKIIα and S831-GluA1 phosphorylation.</p>
</sec>
<sec id="S21">
<title>Activation of Ca<sub>v</sub>1.3 channels in the VTA promotes depressive-like behavior, cocaine-related behavior, and induces deficits in social behavior</title>
<p id="P27">To determine whether VTA Ca<sub>v</sub>1.3 channel manipulation is sufficient to alter mood-related and social behavior we used a repeated Ca<sub>v</sub>1.3 channel activation protocol (BayK, once a day for 3 days, <xref ref-type="fig" rid="F3">Figure 3a</xref>) in the VTA of Ca<sub>v</sub>1.2DHP<sup>−/−</sup> mice, which has previously been shown to induce long-term behavioral changes in response to cocaine<sup><xref ref-type="bibr" rid="R14">14</xref></sup>. Repeated VTA-BayK infusion induced anhedonia in the sucrose preference test (SPT) and increased immobility in the forced swim test (FST), when tested 30 days after the last BayK infusion (<xref ref-type="fig" rid="F3">Figure 3b, c</xref>). In a separate cohort, we also observed that BayK effects emerged as early as 24 hours after the last BayK infusion (<xref ref-type="supplementary-material" rid="SD7">Supplementary Figure 3a–b</xref>). VTA-BayK treatment also decreased social approach behavior in the three-chamber social interaction test (<xref ref-type="fig" rid="F3">Figure 3d</xref>, <xref ref-type="supplementary-material" rid="SD7">Supplementary Figure 3c</xref>). As previously reported<sup><xref ref-type="bibr" rid="R14">14</xref></sup>, VTA-BayK also potentiated cocaine-induced locomotor activity when measured 30 days after the last BayK infusion (<xref ref-type="supplementary-material" rid="SD7">Supplementary Figure 3g</xref>) but not 24 hours later (<xref ref-type="supplementary-material" rid="SD7">Supplementary Figure 3d</xref>). VTA-BayK infusions had no effect on anxiety-like behavior or basal locomotor activity at either time point (<xref ref-type="supplementary-material" rid="SD7">Supplementary Figure 3e–f, h–i</xref>). Of note, repeated systemic BayK administration in Ca<sub>v</sub>1.2DHP<sup>−/−</sup> mice had a similar effect on SPT, FST, social and cocaine-related behaviors, with no effect on EPM and basal locomotor activity (<xref ref-type="supplementary-material" rid="SD7">Supplementary Figure 3j–o</xref>). Thus, activation of Ca<sub>v</sub>1.3 channels in the VTA is sufficient to induce mood-related and cocaine behaviors that are long lasting. In contrast to VTA Ca<sub>v</sub>1.3 activation, inhibition of Ca<sub>v</sub>1.3 with repeated nifedipine had no effect on depressive-like, social or cocaine induced-locomotion when measured 24 hours after the last nifedipine infusion (<xref ref-type="supplementary-material" rid="SD8">Supplementary Figure 4a–d</xref>) and had a milder effect 30 days later (<xref ref-type="supplementary-material" rid="SD8">Supplementary Figure 4g–j</xref>) with no effect on anxiety-like behavior or basal locomotion (<xref ref-type="supplementary-material" rid="SD8">Supplementary Figure 4e–f, k–l</xref>).</p>
</sec>
<sec id="S22">
<title>CP-AMPARs in the NAc shell mediate BayK-induced cocaine and depressive-like behavior</title>
<p id="P28">Formation of CP-AMPARs in the NAc has been reported in models of chronic stress<sup><xref ref-type="bibr" rid="R36">36</xref></sup> and chronic neuropathic pain-induced depressive-like behaviors<sup><xref ref-type="bibr" rid="R49">49</xref></sup>. Thus, we measured levels of GluA1 and GluA2 in NAc (shell and core) PSD fractions 30 days following VTA-BayK infusions and both were higher in BayK infused mice (<xref ref-type="fig" rid="F3">Figure 3e</xref>). Interestingly, even though BayK induced depressive-like and social behavioral deficits 24 hours after the last BayK administration, neither GluA1 nor GluA2 were significantly altered at 24 hours (<xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 5a</xref>). To test the potential role of CP-AMPARs in VTA BayK-induced behaviors at the 30d time point, given overlapping mechanisms<sup><xref ref-type="bibr" rid="R8">8</xref></sup>, Naspm was administered into the NAc shell 30 mins prior to behavioral testing (<xref ref-type="fig" rid="F3">Figure 3f</xref>), a manipulation that blocked VTA BayK-induced decrease in SPT (<xref ref-type="fig" rid="F3">Figure 3g</xref>) and increase in immobility during FST (<xref ref-type="fig" rid="F3">Figure 3h</xref>) (no effect on vehicle treated mice). Naspm additionally attenuated enhanced cocaine-induced locomotor activity in BayK-treated mice (<xref ref-type="fig" rid="F3">Figure 3i</xref>). Interestingly, Naspm in the NAc shell had no effect on social approach behavior (<xref ref-type="fig" rid="F3">Figure 3j</xref>) nor in the NAc core (<xref ref-type="fig" rid="F3">Figure 3k</xref>), whereas blocking GluA1/A2 AMPARs with NBQX in the NAc core (<xref ref-type="fig" rid="F3">Figure 3l</xref>, <xref ref-type="supplementary-material" rid="SD9">Supplementary Figure 5b</xref>) but not in the NAc shell (<xref ref-type="fig" rid="F3">Figure 3m</xref>), reversed the deficit in social approach. Thus, long-term effect of repeated VTA-BayK on depressive behavior results from increase in CP-AMPARs in the NAc shell, whereas its effect on social behavior results from increase in GluA1/A2 AMPARs in the NAc core.</p>
<p id="P29">Next, we tested if repeated VTA-BayK alters protein kinase and GluA1 phosphorylation levels in the NAc. Similar to cocaine exposure (<xref ref-type="fig" rid="F2">Figure 2h</xref>), we found that VTA-BayK infusion increased levels of NAc CaMKIIα, and S831-GluA1 30 days following BayK infusion (<xref ref-type="fig" rid="F4">Figure 4a</xref>). To test the causal role of S831-GluA1 phosphorylation on behaviors, we utilized S831A-GluA1 phospho-mutant mice. At baseline, S831A did not differ from WT mice in the SPT (<xref ref-type="supplementary-material" rid="SD10">Supplementary Figure 6a</xref>), FST (<xref ref-type="supplementary-material" rid="SD10">Supplementary Figure 6b</xref>), social behavior (<xref ref-type="supplementary-material" rid="SD10">Supplementary Figure 6c</xref>), EPM (<xref ref-type="supplementary-material" rid="SD10">Supplementary Figure 6d</xref>), or basal locomotor activity (<xref ref-type="supplementary-material" rid="SD10">Supplementary Figure 6e</xref>). In contrast, VTA BayK-induced anhedonia (<xref ref-type="fig" rid="F4">Figure 4b</xref>), increased immobility (<xref ref-type="fig" rid="F4">Figure 4c</xref>), and enhanced cocaine-induced locomotor activity (<xref ref-type="fig" rid="F4">Figure 4e</xref>) were not observed in S831A mice. Interestingly, WT and mutant mice exhibited similar social approach behavior (<xref ref-type="fig" rid="F4">Figure 4d</xref>), demonstrating a causal role of S831-GluA1 phosphorylation in the NAc for VTA BayK-induced depressive-like and cocaine-related behaviors, but not social behavior. VTA-BayK infusions had no effect on anxiety-like behavior or basal locomotor activity in either genotype (<xref ref-type="supplementary-material" rid="SD10">Supplementary Figure 6f–g</xref>).</p>
</sec>
<sec id="S23">
<title>Significant association of <italic>CACNA1D</italic> SNPs with cocaine dependence</title>
<p id="P30">Based on our findings of a role for Ca<sub>v</sub>1.3 channels in rodent cocaine behaviors, we tested whether variants within and around <italic>CACNA1D</italic> were associated with CD using the genomewide association study (GWAS data set from the Study of Addiction: Genetics and Environment (SAGE)). To examine as many variants as possible, we imputed the 1000 Genomes Project variants into <italic>CACNA1D</italic>. Specifically, we tested 947 single nucleotide polymorphism (SNPs) within and around <italic>CACNA1D</italic> in European-Americans (EA; 493 cases and 1,058 controls) and followed analyses of any significant findings in African-Americans (AA; 521 cases and 369 controls). We performed an association test in a logistic regression framework including sex, age and top three principle components as covariates. We found the strongest association with CD for intronic SNP rs4687735 in EAs (p = 1.3 × 10<sup>−5</sup>, OR = 2.46, 95% Confidence Interval (CI) = 1.65–3.67), an imputed intronic SNP (imputation quality score = 0.82) with a risk allele ‘T’ frequency of 6.5% in cases and 3.5% in controls, which remains significant after Bonferroni correction (p = 0.012). In addition, another two imputed SNPs, rs2926559 and rs898407, which are in high linkage disequilibrium (LD) with rs4687735, also showed strong association with CD (rs2926559, p=0.018 and rs898407, p=0.019 after Bonferroni correction). <xref ref-type="fig" rid="F5">Figure 5</xref> illustrates the association test results for 947 SNPs within and around <italic>CACNA1D</italic> in EAs.</p>
<p id="P31">We observed a trend association in the same direction as in EAs for rs4687735 in AAs (p = 0.14, OR = 2.62, 95% CI = 0.68–10.15), with risk allele ‘T’ frequency of 1.1% in cases and 0.45% in controls (imputation quality score = 0.88). Meta-analysis of the EA and AA samples showed stronger association between rs4687735 and CD (p=4.0×10<sup>−6</sup>, OR = 2.47, 95% CI = 1.68–3.63). We also observed trend associations for the rs2926559 (p = 0.13, OR = 2.42, 95% CI = 0.72–8.07) and rs898407 (p = 0.14, OR = 2.51, 95% CI = 0.68–9.23) in AAs. <xref ref-type="supplementary-material" rid="SD11">Supplementary Table 5</xref> shows association results for EAs, AAs and meta-analysis for 778 SNPs that exist in both EAs and AAs.</p>
<p id="P32">To evaluate the association evidence at the gene level, we further computed a gene-based p-value for the EA and AA samples using GATES, a gene-based association test using extended Simes procedure<sup><xref ref-type="bibr" rid="R50">50</xref></sup>. We found significant association evidence in both EA (p=0.003) and AA (p=0.008).</p>
</sec>
</sec>
<sec id="S24" sec-type="discussion">
<title>DISCUSSION</title>
<p id="P33">Here, we demonstrate that VTA Ca<sub>v</sub>1.3 channel activation robustly mediates cocaine-related, depression-related and social behavior via distinct NAc AMPAR mechanisms with no effect on anxiety-like behavior. These findings provide novel insight into VTA Ca<sub>v</sub>1.3 to NAc mechanisms that likely underlie behavioral phenotypes in multiple neuropsychiatric illnesses. We propose that Ca<sub>v</sub>1.3 activation may mediate co-morbid phenotypes in addiction and mood disorders. Our identification of <italic>CACNA1D</italic> SNPs associated with cocaine dependence, in combination with previous human genetic data linking <italic>CACNA1D</italic> with BD<sup><xref ref-type="bibr" rid="R11">11</xref>, <xref ref-type="bibr" rid="R12">12</xref></sup>, suggests a potential role for VTA <italic>CACNA1D</italic> in mediating co-morbid behavioral endophenotypes in addiction and BD. The data also support further investigation of Ca<sub>v</sub>1.3 as a potential therapeutic target for neuropsychiatric disorders with substance abuse, depression or social deficit-related phenotypes.</p>
<p id="P34">The current findings add to the emerging evidence for convergent mesolimbic dopamine pathway mechanisms mediating behavioral deficits in reward-related and mood disorders<sup><xref ref-type="bibr" rid="R2">2</xref>, <xref ref-type="bibr" rid="R7">7</xref>, <xref ref-type="bibr" rid="R51">51</xref></sup>. Our study is the first to examine Ca<sub>v</sub>1.3 mechanisms across drug-related, depression-related and social-related behaviors and the first to link Ca<sub>v</sub>1.3 animal studies to human GWAS data. The ability of VTA Ca<sub>v</sub>1.3 activation to enhance cocaine behaviors after extended withdrawal is consistent with previous demonstration of VTA LTCC activation potentiating cocaine-induced psychomotor response<sup><xref ref-type="bibr" rid="R14">14</xref></sup> and with a critical role of VTA Ca<sub>v</sub>1.3 LTCCs in cocaine behaviors<sup><xref ref-type="bibr" rid="R15">15</xref>, <xref ref-type="bibr" rid="R16">16</xref></sup>. The observed depressive-like effects of VTA Ca<sub>v</sub>1.3 activation are consistent with our previous demonstration where global Ca<sub>v</sub>1.3 activation resulted in depressive-like behavior<sup><xref ref-type="bibr" rid="R28">28</xref></sup>, while Ca<sub>v</sub>1.3<sup>−/−</sup> mice showed an antidepressant-like response<sup><xref ref-type="bibr" rid="R52">52</xref></sup>. We additionally show for the first time that VTA Ca<sub>v</sub>1.3 channel activation results in social behavioral deficits. The novelty of the present finding is our identification of the VTA as a critical brain locus mediating these Ca<sub>v</sub>1.3-dependent depressive-like and social behavioral phenotypes in parallel with cocaine-induced phenotypes. Thus, we demonstrate for the first time that enhancing VTA Ca<sub>v</sub>1.3 activation is a common mechanism that can induce behavioral alterations associated with substance abuse and mood-related psychiatric illnesses. Indeed, multiple investigations over the last several years have begun to elucidate specific VTA mechanisms that are activated by stress and by drugs of abuse<sup><xref ref-type="bibr" rid="R6">6</xref>, <xref ref-type="bibr" rid="R8">8</xref>, <xref ref-type="bibr" rid="R51">51</xref></sup>.</p>
<p id="P35">Importantly, our findings provide novel pathway-specific molecular insights regarding the mechanisms underlying these reward, mood, and social interaction-related behaviors. Our data show that activation of VTA Ca<sub>v</sub>1.3 channels is sufficient to increase CP-AMPARs in the NAc shell; their activation, in turn, is necessary for cocaine CPP and enhanced locomotor response measured after greater than 1 month, but not 1 day, of withdrawal. These findings are generally consistent with a role for cocaine-evoked CP-AMPARs in the NAc shell in certain models of addictive behavior, although most such evidence has been obtained after cocaine self-administration<sup><xref ref-type="bibr" rid="R31">31</xref>–<xref ref-type="bibr" rid="R35">35</xref>, <xref ref-type="bibr" rid="R53">53</xref>–<xref ref-type="bibr" rid="R55">55</xref></sup>. Cocaine-evoked CP-AMPARs in NAc core also mediate cocaine seeking after cocaine self-administration and prolonged withdrawal<sup><xref ref-type="bibr" rid="R30">30</xref>, <xref ref-type="bibr" rid="R54">54</xref>–<xref ref-type="bibr" rid="R56">56</xref></sup>. It will be interesting in future studies to further examine NAc core versus shell AMPAR mechanisms in the model used in this study.</p>
<p id="P36">We further demonstrate that similar to cocaine, VTA Ca<sub>v</sub>1.3-induced depressive-like behavior results from increase in CP-AMPARs in the NAc shell. While the role of CP-AMPARs in depressive-like behavior has not been clearly delineated in the literature, recent studies have revealed changes in CP-AMPAR expression that are associated with exposure to a stress protocol that induces anhedonia<sup><xref ref-type="bibr" rid="R36">36</xref></sup>. Vialou V. et al. 2010<sup><xref ref-type="bibr" rid="R57">57</xref></sup> also showed that mice susceptible to social defeat stress show higher levels of GluA1 expression in the NAc, with no change in GluA2 suggestive of an increase in CP-AMPARs. Additionally, CP-AMPARs in the NAc have been found to emerge in a chronic neuropathic pain-induced depression model<sup><xref ref-type="bibr" rid="R49">49</xref></sup>. Collectively these studies support the conclusion that VTA Ca<sub>v</sub>1.3 activation promotes cocaine and depressive-like behavior via enhancing synaptic CP-AMPARs. One mechanism suggested to contribute to increases in CP-AMPAR levels at the synapse is S831-GluA1 phosphorylation by CaMKIIα<sup><xref ref-type="bibr" rid="R48">48</xref></sup>. We demonstrate the necessity of S831-GluA1 phosphorylation for VTA Ca<sub>v</sub>1.3-mediated enhancement of cocaine and depressive-like behaviors, highlighting VTA Ca<sub>v</sub>1.3 mechanistic convergence. The ability of VTA Ca<sub>v</sub>1.3 activation to increase NAc CaMKIIα activity also argues for a converging CaMKIIα mechanism. Previous studies have found an increase in CaMKIIα in the NAc of rats following 14 days of withdrawal from non-contingent cocaine administration<sup><xref ref-type="bibr" rid="R58">58</xref></sup> and in the NAc of cocaine-dependent humans<sup><xref ref-type="bibr" rid="R58">58</xref></sup>, as well as following social defeat stress<sup><xref ref-type="bibr" rid="R59">59</xref></sup>. Additionally, a SNP in the <italic>CaMK2A</italic> gene has been linked to faster transition to severe cocaine use in humans<sup><xref ref-type="bibr" rid="R60">60</xref></sup>. A direct link between CaMKIIα and formation of CP-AMPARs remains to be established, however concurrent increase in phosphorylated CaMKII and CP-AMPARs at the NAc PSD following extended withdrawal from cocaine self-administration has been observed<sup><xref ref-type="bibr" rid="R61">61</xref></sup>.</p>
<p id="P37">We additionally demonstrate that activation of VTA Ca<sub>v</sub>1.3 channels also promotes social deficits however via enhancing GluA1/A2 AMPARs in the NAc consistent with enhanced AMPAR transmission associated with social deficits<sup><xref ref-type="bibr" rid="R62">62</xref></sup> including in the NAc core<sup><xref ref-type="bibr" rid="R63">63</xref></sup>. To the best of our knowledge, this is the first time that Ca<sub>v</sub>1.3 channels have been associated with social behavior. The recruitment of AMPARs in the NAc core versus CP-AMPARs in the NAc shell in our models of cocaine and depressive-like phenotypes suggests the possibility of recruitment of different VTA-NAc neurons mediating diverse behavioral phenotypes. This is not surprising given the highly heterogeneous nature of the VTA afferents to the NAc and other regions of the brain<sup><xref ref-type="bibr" rid="R26">26</xref>, <xref ref-type="bibr" rid="R64">64</xref></sup>, a question that will be addressed in future studies. Additionally, the higher but not significant levels of S880 P-GluA2 in the PSD of NAc (core+shell) is intriguing given that this phosphorylation event has been suggested to endocytose GluA2 subunits<sup><xref ref-type="bibr" rid="R65">65</xref>, <xref ref-type="bibr" rid="R66">66</xref></sup>. However, States et al. (2008)<sup><xref ref-type="bibr" rid="R67">67</xref></sup> have reported that S880 phosphorylation can stabilize GluA2 at the PSD, that could be the case in the NAc core where we find higher GluA1/GluA2 AMPARs. In future studies, it will be interesting to further explore the role of S880 GluA2 phosphorylation in GluA2 trafficking and social behavior.</p>
<p id="P38">The precise VTA Ca<sub>v</sub>1.3 mechanisms that promote cocaine and depressive-like behaviors remain to be answered. Preliminary findings from our laboratory suggest that Ca<sub>v</sub>1.3/CaMKII/ERK2 signaling within the VTA mediates long-term molecular changes in the NAc via a CREB-dependent mechanism. CREB in the VTA has been suggested to play a role in cocaine-induced plasticity<sup><xref ref-type="bibr" rid="R68">68</xref></sup>, an area of research that remains underexplored. One potential candidate downstream of the Ca<sub>v</sub>1.3/CREB pathway in the VTA that may mediate the transition from the VTA to NAc is the neurotrophic factor BDNF, a downstream target of LTCCs<sup><xref ref-type="bibr" rid="R69">69</xref>, <xref ref-type="bibr" rid="R70">70</xref></sup> and of CREB<sup><xref ref-type="bibr" rid="R71">71</xref>, <xref ref-type="bibr" rid="R72">72</xref></sup> that regulates both cocaine<sup><xref ref-type="bibr" rid="R73">73</xref></sup> and depressive-like behavior<sup><xref ref-type="bibr" rid="R74">74</xref></sup>. Phasic firing of VTA dopamine neurons promotes cocaine-<sup><xref ref-type="bibr" rid="R25">25</xref></sup> and depressive behaviors<sup><xref ref-type="bibr" rid="R26">26</xref></sup>, a dopamine neuron property that also facilitates BDNF release in the NAc<sup><xref ref-type="bibr" rid="R8">8</xref></sup>. BDNF in the NAc via its postsynaptic TrkB receptor, regulates CaMKII-mediated S831 GluA1 phosphorylation<sup><xref ref-type="bibr" rid="R75">75</xref></sup>, AMPAR trafficking<sup><xref ref-type="bibr" rid="R76">76</xref>, <xref ref-type="bibr" rid="R77">77</xref></sup> and cocaine and depressive behaviors<sup><xref ref-type="bibr" rid="R73">73</xref>, <xref ref-type="bibr" rid="R74">74</xref>, <xref ref-type="bibr" rid="R78">78</xref></sup>. Thus, BDNF produced in the VTA and released in the NAc serves as a promising candidate in mediating the effect of VTA Ca<sub>v</sub>1.3 channels. Our unpublished data supports this hypothesis as we find that VTA Ca<sub>v</sub>1.3 channel activation increases <italic>Bdnf</italic> transcription in the VTA. Future studies will address VTA Cav1.3-mediated Bdnf release and postsynaptic effects in the NAc on AMPAR signaling and cocaine and mood-related behaviors.</p>
<p id="P39">Candidate gene association analysis in humans supports the role of genetic variations within <italic>CACNA1D</italic> in CD. To the best of knowledge, this is the first report describing a genetic association between <italic>CACNA1D</italic> and CD in two independent human samples, which corroborates the functional aspects of Ca<sub>v</sub>1.3 in the mice models of cocaine behavior. Considering the fact that <italic>CACNA1D</italic> SNPs can confer risk for BD<sup><xref ref-type="bibr" rid="R11">11</xref>, <xref ref-type="bibr" rid="R12">12</xref></sup> as well as the association of human <italic>CACNA1D</italic> gain of function mutations associated with neurological disorders<sup><xref ref-type="bibr" rid="R10">10</xref></sup>, including autism<sup><xref ref-type="bibr" rid="R13">13</xref></sup>, characterized by significant mood dysregulation, an important follow-up investigation would be to examine via targeted sequencing whether rare variants within <italic>CACNA1D</italic> are also associated with CD. Further fine-mapping of this gene may contribute to the identification of functional causal variants underlying CD.</p>
<p id="P40">In summary, findings of this study support enhanced Ca<sub>v</sub>1.3 channel activity within the VTA-NAc pathway as one potential mechanism underlying drug abuse and mood disorders, with implications for co-morbid neuropsychiatric-related behavioral phenotypes, in particular those resulting from disease-associated <italic>CACNA1D</italic> SNPs. The study provides a novel framework to further understand the pathophysiology of mental illness that can aid in designing therapeutic studies using available Ca<sub>v</sub>1.3-selective LTCC blockers<sup><xref ref-type="bibr" rid="R79">79</xref></sup>.</p>
</sec>
<sec id="S25" sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<label>1</label>
<media id="d36e1504" orientation="portrait" position="anchor" xlink:href="NIHMS839087-supplement-1.ai" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD2">
<label>10</label>
<media id="d36e1508" orientation="portrait" position="anchor" xlink:href="NIHMS839087-supplement-10.docx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD3">
<label>11</label>
<media id="d36e1512" orientation="portrait" position="anchor" xlink:href="NIHMS839087-supplement-11.xlsx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD4">
<label>12</label>
<media id="d36e1516" orientation="portrait" position="anchor" xlink:href="NIHMS839087-supplement-12.xlsx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD5">
<label>13</label>
<media id="d36e1520" orientation="portrait" position="anchor" xlink:href="NIHMS839087-supplement-13.docx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD6">
<label>2</label>
<media id="d36e1524" orientation="portrait" position="anchor" xlink:href="NIHMS839087-supplement-2.ai" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD7">
<label>3</label>
<media id="d36e1528" orientation="portrait" position="anchor" xlink:href="NIHMS839087-supplement-3.ai" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD8">
<label>4</label>
<media id="d36e1532" orientation="portrait" position="anchor" xlink:href="NIHMS839087-supplement-4.ai" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD9">
<label>5</label>
<media id="d36e1536" orientation="portrait" position="anchor" xlink:href="NIHMS839087-supplement-5.ai" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD10">
<label>6</label>
<media id="d36e1540" orientation="portrait" position="anchor" xlink:href="NIHMS839087-supplement-6.ai" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD11">
<label>7</label>
<media id="d36e1545" orientation="portrait" position="anchor" xlink:href="NIHMS839087-supplement-7.docx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD12">
<label>8</label>
<media id="d36e1549" orientation="portrait" position="anchor" xlink:href="NIHMS839087-supplement-8.docx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD13">
<label>9</label>
<media id="d36e1553" orientation="portrait" position="anchor" xlink:href="NIHMS839087-supplement-9.docx" xlink:type="simple"></media>
</supplementary-material>
</sec>
</body>
<back>
<ack id="S26">
<p>This work was supported by the National Institute of Health Grants 5R01DA029122-04 (AMRajadhyaksha), R01AA022994 (SH), R21DA038048 (NAA and AMRajadhyaksha) and the NIDA Diversity Supplement 3R01DA029122-04S2 (AMartínez-Rivera).</p>
<p>The SAGE GWAS dataset used for the analyses described in this manuscript were obtained from <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gap">http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gap</ext-link> through dbGaP accession number phs000092.v1.p. Funding support for the Study of Addiction: Genetics and Environment (SAGE) was provided through the NIH Genes, Environment and Health Initiative [GEI] (U01 HG004422). SAGE is one of the genomewide association studies funded as part of the Gene Environment Association Studies (GENEVA) under GEI. Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by the GENEVA Coordinating Center (U01 HG004446). Assistance with data cleaning was provided by the National Center for Biotechnology Information. Support for collection of datasets and samples was provided by the Collaborative Study on the Genetics of Alcoholism (COGA; U10 AA008401), the Collaborative Genetic Study of Nicotine Dependence (COGEND; P01 CA089392), and the Family Study of Cocaine Dependence (FSCD; R01 DA013423). Funding support for genotyping, which was performed at the Johns Hopkins University Center for Inherited Disease Research, was provided by the NIH GEI (U01HG004438), the National Institute on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse, and the NIH contract “High throughput genotyping for studying the genetic contributions to human disease” (HHSN268200782096C).</p>
</ack>
<fn-group>
<fn fn-type="COI-statement" id="FN3">
<p>
<bold>Conflict of Interest</bold>
</p>
<p>None</p>
</fn>
<fn fn-type="con" id="FN4">
<p>
<bold>Author Contributions</bold>
</p>
<p>AM-R, JH, TFT, TPG, NAA and AMR contributed to the overall experimental design, and data interpretation. AM-R, NAA and AMR wrote the manuscript. AL, RLH, and JS provided reagents and edited the manuscript. MK and RCR performed research, analyzed data and edited the paper. SH contributed to the design and performed the GWAS and wrote the manuscript.</p>
</fn>
</fn-group>
<ref-list>
<ref id="R1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Whitton</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Treadway</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Pizzagalli</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Reward processing dysfunction in major depression, bipolar disorder and schizophrenia</article-title>
<source/>Curr Opin Psychiatry
          <year>2015</year>
<volume>28</volume>
<issue>1</issue>
<fpage>7</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="pmid">25415499</pub-id>
</element-citation>
</ref>
<ref id="R2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Post</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Kalivas</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Bipolar disorder and substance misuse: pathological and therapeutic implications of their comorbidity and cross-sensitisation</article-title>
<source/>Br J Psychiatry
          <year>2013</year>
<volume>202</volume>
<issue>3</issue>
<fpage>172</fpage>
<lpage>176</lpage>
<pub-id pub-id-type="pmid">23457180</pub-id>
</element-citation>
</ref>
<ref id="R3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kessler</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Chiu</surname>
<given-names>WT</given-names>
</name>
<name>
<surname>Demler</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Merikangas</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Walters</surname>
<given-names>EE</given-names>
</name>
</person-group>
<article-title>Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication</article-title>
<source/>Arch Gen Psychiatry
          <year>2005</year>
<volume>62</volume>
<issue>6</issue>
<fpage>617</fpage>
<lpage>627</lpage>
<pub-id pub-id-type="pmid">15939839</pub-id>
</element-citation>
</ref>
<ref id="R4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kendler</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Prescott</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Neale</surname>
<given-names>MC</given-names>
</name>
</person-group>
<article-title>The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women</article-title>
<source/>Arch Gen Psychiatry
          <year>2003</year>
<volume>60</volume>
<issue>9</issue>
<fpage>929</fpage>
<lpage>937</lpage>
<pub-id pub-id-type="pmid">12963675</pub-id>
</element-citation>
</ref>
<ref id="R5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goldman</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Oroszi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ducci</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>The genetics of addictions: uncovering the genes</article-title>
<source/>Nat Rev Genet
          <year>2005</year>
<volume>6</volume>
<issue>7</issue>
<fpage>521</fpage>
<lpage>532</lpage>
<pub-id pub-id-type="pmid">15995696</pub-id>
</element-citation>
</ref>
<ref id="R6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nestler</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Carlezon</surname>
<given-names>WA</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<article-title>The mesolimbic dopamine reward circuit in depression</article-title>
<source/>Biol Psychiatry
          <year>2006</year>
<volume>59</volume>
<issue>12</issue>
<fpage>1151</fpage>
<lpage>1159</lpage>
<pub-id pub-id-type="pmid">16566899</pub-id>
</element-citation>
</ref>
<ref id="R7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luthi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Luscher</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Pathological circuit function underlying addiction and anxiety disorders</article-title>
<source/>Nat Neurosci
          <year>2014</year>
<volume>17</volume>
<issue>12</issue>
<fpage>1635</fpage>
<lpage>1643</lpage>
<pub-id pub-id-type="pmid">25402855</pub-id>
</element-citation>
</ref>
<ref id="R8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Russo</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Nestler</surname>
<given-names>EJ</given-names>
</name>
</person-group>
<article-title>The brain reward circuitry in mood disorders</article-title>
<source/>Nat Rev Neurosci
          <year>2013</year>
<volume>14</volume>
<issue>9</issue>
<fpage>609</fpage>
<lpage>625</lpage>
<pub-id pub-id-type="pmid">23942470</pub-id>
</element-citation>
</ref>
<ref id="R9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kabir</surname>
<given-names>ZD</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Rajadhyaksha</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>L-type Ca2+ channels in mood, cognition and addiction: Integrating human and rodent studies with a focus on behavioural endophenotypes</article-title>
<source/>J Physiol
          <year>2016</year>
</element-citation>
</ref>
<ref id="R10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinggera</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Striessnig</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Cav 1.3 (CACNA1D) L-type Ca2+ channel dysfunction in CNS disorders</article-title>
<source/>J Physiol
          <year>2016</year>
</element-citation>
</ref>
<ref id="R11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ament</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Szelinger</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Glusman</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ashworth</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Akula</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rare variants in neuronal excitability genes influence risk for bipolar disorder</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2015</year>
<volume>112</volume>
<issue>11</issue>
<fpage>3576</fpage>
<lpage>3581</lpage>
<pub-id pub-id-type="pmid">25730879</pub-id>
</element-citation>
</ref>
<ref id="R12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ross</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gedvilaite</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Badner</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Erdman</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Baird</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Matsunami</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A Rare Variant in CACNA1D Segregates with 7 Bipolar I Disorder Cases in a Large Pedigree</article-title>
<source/>Mol Neuropsychiatry
          <year>2016</year>
<volume>2</volume>
<issue>3</issue>
<fpage>145</fpage>
<lpage>150</lpage>
<pub-id pub-id-type="pmid">27867939</pub-id>
</element-citation>
</ref>
<ref id="R13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinggera</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lieb</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Benedetti</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lampert</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Monteleone</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Liedl</surname>
<given-names>KR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CACNA1D de novo mutations in autism spectrum disorders activate Cav1.3 L-type calcium channels</article-title>
<source/>Biol Psychiatry
          <year>2015</year>
<volume>77</volume>
<issue>9</issue>
<fpage>816</fpage>
<lpage>822</lpage>
<pub-id pub-id-type="pmid">25620733</pub-id>
</element-citation>
</ref>
<ref id="R14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Licata</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>AY</given-names>
</name>
<name>
<surname>Pierce-Bancroft</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Pierce</surname>
<given-names>RC</given-names>
</name>
</person-group>
<article-title>Repeated stimulation of L-type calcium channels in the rat ventral tegmental area mimics the initiation of behavioral sensitization to cocaine</article-title>
<source/>Psychopharmacology (Berl)
          <year>2000</year>
<volume>152</volume>
<issue>1</issue>
<fpage>110</fpage>
<lpage>118</lpage>
<pub-id pub-id-type="pmid">11041323</pub-id>
</element-citation>
</ref>
<ref id="R15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schierberl</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tropea</surname>
<given-names>TF</given-names>
</name>
<name>
<surname>Ra</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Giordano</surname>
<given-names>TP</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Q</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cav1.2 L-type Ca(2)(+) channels mediate cocaine-induced GluA1 trafficking in the nucleus accumbens, a long-term adaptation dependent on ventral tegmental area Ca(v)1. 3 channels</article-title>
<source/>J Neurosci
          <year>2011</year>
<volume>31</volume>
<issue>38</issue>
<fpage>13562</fpage>
<lpage>13575</lpage>
<pub-id pub-id-type="pmid">21940447</pub-id>
</element-citation>
</ref>
<ref id="R16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Degoulet</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Stelly</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Ahn</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Morikawa</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>L-type Ca(2)(+) channel blockade with antihypertensive medication disrupts VTA synaptic plasticity and drug-associated contextual memory</article-title>
<source/>Mol Psychiatry
          <year>2016</year>
<volume>21</volume>
<issue>3</issue>
<fpage>394</fpage>
<lpage>402</lpage>
<pub-id pub-id-type="pmid">26100537</pub-id>
</element-citation>
</ref>
<ref id="R17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stanika</surname>
<given-names>RI</given-names>
</name>
<name>
<surname>Flucher</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Obermair</surname>
<given-names>GJ</given-names>
</name>
</person-group>
<article-title>Regulation of Postsynaptic Stability by the L-type Calcium Channel CaV1. 3 and its Interaction with PDZ Proteins</article-title>
<source/>Curr Mol Pharmacol
          <year>2015</year>
<volume>8</volume>
<issue>1</issue>
<fpage>95</fpage>
<lpage>101</lpage>
<pub-id pub-id-type="pmid">25966696</pub-id>
</element-citation>
</ref>
<ref id="R18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajadhyaksha</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Kosofsky</surname>
<given-names>BE</given-names>
</name>
</person-group>
<article-title>Psychostimulants, L-type calcium channels, kinases, and phosphatases</article-title>
<source/>Neuroscientist
          <year>2005</year>
<volume>11</volume>
<issue>5</issue>
<fpage>494</fpage>
<lpage>502</lpage>
<pub-id pub-id-type="pmid">16151049</pub-id>
</element-citation>
</ref>
<ref id="R19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pascoli</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Terrier</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hiver</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Luscher</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Sufficiency of Mesolimbic Dopamine Neuron Stimulation for the Progression to Addiction</article-title>
<source/>Neuron
          <year>2015</year>
<volume>88</volume>
<issue>5</issue>
<fpage>1054</fpage>
<lpage>1066</lpage>
<pub-id pub-id-type="pmid">26586182</pub-id>
</element-citation>
</ref>
<ref id="R20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tye</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Mirzabekov</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Warden</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Ferenczi</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Finkelstein</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dopamine neurons modulate neural encoding and expression of depression-related behaviour</article-title>
<source/>Nature
          <year>2013</year>
<volume>493</volume>
<issue>7433</issue>
<fpage>537</fpage>
<lpage>541</lpage>
<pub-id pub-id-type="pmid">23235822</pub-id>
</element-citation>
</ref>
<ref id="R21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaudhury</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Juarez</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ku</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Koo</surname>
<given-names>JW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons</article-title>
<source/>Nature
          <year>2013</year>
<volume>493</volume>
<issue>7433</issue>
<fpage>532</fpage>
<lpage>536</lpage>
<pub-id pub-id-type="pmid">23235832</pub-id>
</element-citation>
</ref>
<ref id="R22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gunaydin</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Grosenick</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Finkelstein</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Kauvar</surname>
<given-names>IV</given-names>
</name>
<name>
<surname>Fenno</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Adhikari</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Natural neural projection dynamics underlying social behavior</article-title>
<source/>Cell
          <year>2014</year>
<volume>157</volume>
<issue>7</issue>
<fpage>1535</fpage>
<lpage>1551</lpage>
<pub-id pub-id-type="pmid">24949967</pub-id>
</element-citation>
</ref>
<ref id="R23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Dore</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Calcium influx through L-type channels generates protein kinase M to induce burst firing of dopamine cells in the rat ventral tegmental area</article-title>
<source/>J Biol Chem
          <year>2007</year>
<volume>282</volume>
<issue>12</issue>
<fpage>8594</fpage>
<lpage>8603</lpage>
<pub-id pub-id-type="pmid">17237234</pub-id>
</element-citation>
</ref>
<ref id="R24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Harding</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pittman</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dore</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Striessnig</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rajadhyaksha</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cav1.2 and Cav1. 3 L-type calcium channels regulate dopaminergic firing activity in the mouse ventral tegmental area</article-title>
<source/>J Neurophysiol
          <year>2014</year>
<volume>112</volume>
<issue>5</issue>
<fpage>1119</fpage>
<lpage>1130</lpage>
<pub-id pub-id-type="pmid">24848473</pub-id>
</element-citation>
</ref>
<ref id="R25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Covey</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Roitman</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Garris</surname>
<given-names>PA</given-names>
</name>
</person-group>
<article-title>Illicit dopamine transients: reconciling actions of abused drugs</article-title>
<source/>Trends Neurosci
          <year>2014</year>
<volume>37</volume>
<issue>4</issue>
<fpage>200</fpage>
<lpage>210</lpage>
<pub-id pub-id-type="pmid">24656971</pub-id>
</element-citation>
</ref>
<ref id="R26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walsh</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>MH</given-names>
</name>
</person-group>
<article-title>The heterogeneity of ventral tegmental area neurons: Projection functions in a mood-related context</article-title>
<source/>Neuroscience
          <year>2014</year>
<volume>282</volume>
<fpage>101</fpage>
<lpage>108</lpage>
<pub-id pub-id-type="pmid">24931766</pub-id>
</element-citation>
</ref>
<ref id="R27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajadhyaksha</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Husson</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Satpute</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Kuppenbender</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>JQ</given-names>
</name>
<name>
<surname>Guerriero</surname>
<given-names>RM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>L-type Ca2+ channels mediate adaptation of extracellular signal-regulated kinase 1/2 phosphorylation in the ventral tegmental area after chronic amphetamine treatment</article-title>
<source/>J Neurosci
          <year>2004</year>
<volume>24</volume>
<issue>34</issue>
<fpage>7464</fpage>
<lpage>7476</lpage>
<pub-id pub-id-type="pmid">15329393</pub-id>
</element-citation>
</ref>
<ref id="R28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sinnegger-Brauns</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Hetzenauer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>IG</given-names>
</name>
<name>
<surname>Renström</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Wietzorrek</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Berjukov</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Isoform-specific regulation of mood behavior and pancreatic beta cell and cardiovascular function by L-type Ca 2+ channels</article-title>
<source/>J Clin Invest
          <year>2004</year>
<volume>113</volume>
<issue>10</issue>
<fpage>1430</fpage>
<lpage>1439</lpage>
<pub-id pub-id-type="pmid">15146240</pub-id>
</element-citation>
</ref>
<ref id="R29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kourrich</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rothwell</surname>
<given-names>PE</given-names>
</name>
<name>
<surname>Klug</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>Cocaine experience controls bidirectional synaptic plasticity in the nucleus accumbens</article-title>
<source/>J Neurosci
          <year>2007</year>
<volume>27</volume>
<issue>30</issue>
<fpage>7921</fpage>
<lpage>7928</lpage>
<pub-id pub-id-type="pmid">17652583</pub-id>
</element-citation>
</ref>
<ref id="R30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Conrad</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Tseng</surname>
<given-names>KY</given-names>
</name>
<name>
<surname>Uejima</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Reimers</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Heng</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Shaham</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving</article-title>
<source/>Nature
          <year>2008</year>
<volume>454</volume>
<issue>7200</issue>
<fpage>118</fpage>
<lpage>121</lpage>
<pub-id pub-id-type="pmid">18500330</pub-id>
</element-citation>
</ref>
<ref id="R31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mameli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Halbout</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Creton</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Engblom</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Parkitna</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Spanagel</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cocaine-evoked synaptic plasticity: persistence in the VTA triggers adaptations in the NAc</article-title>
<source/>Nat Neurosci
          <year>2009</year>
<volume>12</volume>
<issue>8</issue>
<fpage>1036</fpage>
<lpage>1041</lpage>
<pub-id pub-id-type="pmid">19597494</pub-id>
</element-citation>
</ref>
<ref id="R32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCutcheon</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Tseng</surname>
<given-names>KY</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Marinelli</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Calcium-permeable AMPA receptors are present in nucleus accumbens synapses after prolonged withdrawal from cocaine self-administration but not experimenter-administered cocaine</article-title>
<source/>J Neurosci
          <year>2011</year>
<volume>31</volume>
<issue>15</issue>
<fpage>5737</fpage>
<lpage>5743</lpage>
<pub-id pub-id-type="pmid">21490215</pub-id>
</element-citation>
</ref>
<ref id="R33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pierce</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>Psychostimulant-induced neuroadaptations in nucleus accumbens AMPA receptor transmission</article-title>
<source/>Cold Spring Harb Perspect Med
          <year>2013</year>
<volume>3</volume>
<issue>2</issue>
<fpage>a012021</fpage>
<pub-id pub-id-type="pmid">23232118</pub-id>
</element-citation>
</ref>
<ref id="R34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pascoli</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Terrier</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Espallergues</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Valjent</surname>
<given-names>E</given-names>
</name>
<name>
<surname>O’Connor</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Luscher</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Contrasting forms of cocaine-evoked plasticity control components of relapse</article-title>
<source/>Nature
          <year>2014</year>
<volume>509</volume>
<issue>7501</issue>
<fpage>459</fpage>
<lpage>464</lpage>
<pub-id pub-id-type="pmid">24848058</pub-id>
</element-citation>
</ref>
<ref id="R35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Terrier</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Luscher</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pascoli</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Cell-Type Specific Insertion of GluA2-Lacking AMPARs with Cocaine Exposure Leading to Sensitization, Cue-Induced Seeking, and Incubation of Craving</article-title>
<source/>Neuropsychopharmacology
          <year>2016</year>
<volume>41</volume>
<issue>7</issue>
<fpage>1779</fpage>
<lpage>1789</lpage>
<pub-id pub-id-type="pmid">26585289</pub-id>
</element-citation>
</ref>
<ref id="R36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>KW</given-names>
</name>
<name>
<surname>Grueter</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Rothwell</surname>
<given-names>PE</given-names>
</name>
<name>
<surname>Malenka</surname>
<given-names>RC</given-names>
</name>
</person-group>
<article-title>Anhedonia requires MC4R-mediated synaptic adaptations in nucleus accumbens</article-title>
<source/>Nature
          <year>2012</year>
<volume>487</volume>
<issue>7406</issue>
<fpage>183</fpage>
<lpage>189</lpage>
<pub-id pub-id-type="pmid">22785313</pub-id>
</element-citation>
</ref>
<ref id="R37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hetzenauer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sinnegger-Brauns</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Striessnig</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Singewald</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Brain activation pattern induced by stimulation of L-type Ca2+-channels: contribution of Ca(V)1.3 and Ca(V)1.2 isoforms</article-title>
<source/>Neuroscience
          <year>2006</year>
<volume>139</volume>
<issue>3</issue>
<fpage>1005</fpage>
<lpage>1015</lpage>
<pub-id pub-id-type="pmid">16542784</pub-id>
</element-citation>
</ref>
<ref id="R38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giordano</surname>
<given-names>TP</given-names>
</name>
<name>
<surname>Tropea</surname>
<given-names>TF</given-names>
</name>
<name>
<surname>Satpute</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Sinnegger-Brauns</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Striessnig</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kosofsky</surname>
<given-names>BE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular switch from L-type Ca v 1.3 to Ca v 1.2 Ca2+ channel signaling underlies long-term psychostimulant-induced behavioral and molecular plasticity</article-title>
<source/>J Neurosci
          <year>2010</year>
<volume>30</volume>
<issue>50</issue>
<fpage>17051</fpage>
<lpage>17062</lpage>
<pub-id pub-id-type="pmid">21159975</pub-id>
</element-citation>
</ref>
<ref id="R39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Platzer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Engel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Schrott-Fischer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stephan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bova</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels</article-title>
<source/>Cell
          <year>2000</year>
<volume>102</volume>
<issue>1</issue>
<fpage>89</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="pmid">10929716</pub-id>
</element-citation>
</ref>
<ref id="R40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>HK</given-names>
</name>
<name>
<surname>Takamiya</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Man</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Rumbaugh</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Phosphorylation of the AMPA receptor GluR1 subunit is required for synaptic plasticity and retention of spatial memory</article-title>
<source/>Cell
          <year>2003</year>
<volume>112</volume>
<issue>5</issue>
<fpage>631</fpage>
<lpage>643</lpage>
<pub-id pub-id-type="pmid">12628184</pub-id>
</element-citation>
</ref>
<ref id="R41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tropea</surname>
<given-names>TF</given-names>
</name>
<name>
<surname>Kabir</surname>
<given-names>ZD</given-names>
</name>
<name>
<surname>Kaur</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rajadhyaksha</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Kosofsky</surname>
<given-names>BE</given-names>
</name>
</person-group>
<article-title>Enhanced dopamine D1 and BDNF signaling in the adult dorsal striatum but not nucleus accumbens of prenatal cocaine treated mice</article-title>
<source/>Front Psychiatry
          <year>2011</year>
<volume>2</volume>
<fpage>67</fpage>
<pub-id pub-id-type="pmid">22162970</pub-id>
</element-citation>
</ref>
<ref id="R42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knackstedt</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Moussawi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lalumiere</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Schwendt</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Klugmann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kalivas</surname>
<given-names>PW</given-names>
</name>
</person-group>
<article-title>Extinction training after cocaine self-administration induces glutamatergic plasticity to inhibit cocaine seeking</article-title>
<source/>J Neurosci
          <year>2010</year>
<volume>30</volume>
<issue>23</issue>
<fpage>7984</fpage>
<lpage>7992</lpage>
<pub-id pub-id-type="pmid">20534846</pub-id>
</element-citation>
</ref>
<ref id="R43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calin-Jageman</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Mei</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Erbin enhances voltage-dependent facilitation of Ca(v)1.3 Ca2+ channels through relief of an autoinhibitory domain in the Ca(v)1.3 alpha1 subunit</article-title>
<source/>J Neurosci
          <year>2007</year>
<volume>27</volume>
<issue>6</issue>
<fpage>1374</fpage>
<lpage>1385</lpage>
<pub-id pub-id-type="pmid">17287512</pub-id>
</element-citation>
</ref>
<ref id="R44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tropea</surname>
<given-names>TF</given-names>
</name>
<name>
<surname>Kosofsky</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Rajadhyaksha</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>Enhanced CREB and DARPP-32 phosphorylation in the nucleus accumbens and CREB, ERK, and GluR1 phosphorylation in the dorsal hippocampus is associated with cocaine-conditioned place preference behavior</article-title>
<source/>J Neurochem
          <year>2008</year>
<volume>106</volume>
<issue>4</issue>
<fpage>1780</fpage>
<lpage>1790</lpage>
<pub-id pub-id-type="pmid">18554320</pub-id>
</element-citation>
</ref>
<ref id="R45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Manuszak</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Karakaya</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rajadhyaksha</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Pickel</surname>
<given-names>VM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Energy deficit in parvalbumin neurons leads to circuit dysfunction, impaired sensory gating and social disability</article-title>
<source/>Neurobiol Dis
          <year>2016</year>
<volume>93</volume>
<fpage>35</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="pmid">27105708</pub-id>
</element-citation>
</ref>
<ref id="R46">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Ra</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rajadhyaksha</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Britt</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>De Jesus-Cortes</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Gonzales</surname>
<given-names>KL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Forebrain elimination of cacna1c mediates anxiety-like behavior in mice</article-title>
<source/>Mol Psychiatry
          <year>2012</year>
<volume>17</volume>
<issue>11</issue>
<fpage>1054</fpage>
<lpage>1055</lpage>
<pub-id pub-id-type="pmid">22665262</pub-id>
</element-citation>
</ref>
<ref id="R47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bierut</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Agrawal</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bucholz</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Doheny</surname>
<given-names>KF</given-names>
</name>
<name>
<surname>Laurie</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pugh</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A genome-wide association study of alcohol dependence</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2010</year>
<volume>107</volume>
<issue>11</issue>
<fpage>5082</fpage>
<lpage>5087</lpage>
<pub-id pub-id-type="pmid">20202923</pub-id>
</element-citation>
</ref>
<ref id="R48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huganir</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Nicoll</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>AMPARs and synaptic plasticity: the last 25 years</article-title>
<source/>Neuron
          <year>2013</year>
<volume>80</volume>
<issue>3</issue>
<fpage>704</fpage>
<lpage>717</lpage>
<pub-id pub-id-type="pmid">24183021</pub-id>
</element-citation>
</ref>
<ref id="R49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goffer</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Eberle</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>D’Amour</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tukey</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Calcium-permeable AMPA receptors in the nucleus accumbens regulate depression-like behaviors in the chronic neuropathic pain state</article-title>
<source/>J Neurosci
          <year>2013</year>
<volume>33</volume>
<issue>48</issue>
<fpage>19034</fpage>
<lpage>19044</lpage>
<pub-id pub-id-type="pmid">24285907</pub-id>
</element-citation>
</ref>
<ref id="R50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>MX</given-names>
</name>
<name>
<surname>Gui</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Kwan</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Sham</surname>
<given-names>PC</given-names>
</name>
</person-group>
<article-title>GATES: a rapid and powerful gene-based association test using extended Simes procedure</article-title>
<source/>Am J Hum Genet
          <year>2011</year>
<volume>88</volume>
<issue>3</issue>
<fpage>283</fpage>
<lpage>293</lpage>
<pub-id pub-id-type="pmid">21397060</pub-id>
</element-citation>
</ref>
<ref id="R51">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Polter</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Kauer</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Stress and VTA synapses: implications for addiction and depression</article-title>
<source/>Eur J Neurosci
          <year>2014</year>
<volume>39</volume>
<issue>7</issue>
<fpage>1179</fpage>
<lpage>1188</lpage>
<pub-id pub-id-type="pmid">24712997</pub-id>
</element-citation>
</ref>
<ref id="R52">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Busquet</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>NK</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tanimoto</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Seeliger</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Ben-Yosef</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CaV1.3 L-type Ca2+ channels modulate depression-like behaviour in mice independent of deaf phenotype</article-title>
<source/>Int J Neuropsychopharmacol
          <year>2010</year>
<volume>13</volume>
<issue>4</issue>
<fpage>499</fpage>
<lpage>513</lpage>
<pub-id pub-id-type="pmid">19664321</pub-id>
</element-citation>
</ref>
<ref id="R53">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>BR</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Otaka</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ishikawa</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Maturation of silent synapses in amygdala-accumbens projection contributes to incubation of cocaine craving</article-title>
<source/>Nat Neurosci
          <year>2013</year>
<volume>16</volume>
<issue>11</issue>
<fpage>1644</fpage>
<lpage>1651</lpage>
<pub-id pub-id-type="pmid">24077564</pub-id>
</element-citation>
</ref>
<ref id="R54">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>BR</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bidirectional modulation of incubation of cocaine craving by silent synapse-based remodeling of prefrontal cortex to accumbens projections</article-title>
<source/>Neuron
          <year>2014</year>
<volume>83</volume>
<issue>6</issue>
<fpage>1453</fpage>
<lpage>1467</lpage>
<pub-id pub-id-type="pmid">25199705</pub-id>
</element-citation>
</ref>
<ref id="R55">
<label>55</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wolf</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>Synaptic mechanisms underlying persistent cocaine craving</article-title>
<source/>Nat Rev Neurosci
          <year>2016</year>
<volume>17</volume>
<issue>6</issue>
<fpage>351</fpage>
<lpage>365</lpage>
<pub-id pub-id-type="pmid">27150400</pub-id>
</element-citation>
</ref>
<ref id="R56">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loweth</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Scheyer</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Milovanovic</surname>
<given-names>M</given-names>
</name>
<name>
<surname>LaCrosse</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Flores-Barrera</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Werner</surname>
<given-names>CT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Synaptic depression via mGluR1 positive allosteric modulation suppresses cue-induced cocaine craving</article-title>
<source/>Nat Neurosci
          <year>2014</year>
<volume>17</volume>
<issue>1</issue>
<fpage>73</fpage>
<lpage>80</lpage>
<pub-id pub-id-type="pmid">24270186</pub-id>
</element-citation>
</ref>
<ref id="R57">
<label>57</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vialou</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Robison</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Laplant</surname>
<given-names>QC</given-names>
</name>
<name>
<surname>Covington</surname>
<given-names>HE</given-names>
<suffix>3rd</suffix>
</name>
<name>
<surname>Dietz</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Ohnishi</surname>
<given-names>YN</given-names>
</name>
<etal></etal>
</person-group>
<article-title>DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses</article-title>
<source/>Nat Neurosci
          <year>2010</year>
<volume>13</volume>
<issue>6</issue>
<fpage>745</fpage>
<lpage>752</lpage>
<pub-id pub-id-type="pmid">20473292</pub-id>
</element-citation>
</ref>
<ref id="R58">
<label>58</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robison</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Vialou</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Mazei-Robison</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kourrich</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Behavioral and structural responses to chronic cocaine require a feedforward loop involving DeltaFosB and calcium/calmodulin-dependent protein kinase II in the nucleus accumbens shell</article-title>
<source/>J Neurosci
          <year>2013</year>
<volume>33</volume>
<issue>10</issue>
<fpage>4295</fpage>
<lpage>4307</lpage>
<pub-id pub-id-type="pmid">23467346</pub-id>
</element-citation>
</ref>
<ref id="R59">
<label>59</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robison</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Vialou</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Labonte</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Golden</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Dias</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fluoxetine epigenetically alters the CaMKIIalpha promoter in nucleus accumbens to regulate DeltaFosB binding and antidepressant effects</article-title>
<source/>Neuropsychopharmacology
          <year>2014</year>
<volume>39</volume>
<issue>5</issue>
<fpage>1178</fpage>
<lpage>1186</lpage>
<pub-id pub-id-type="pmid">24240473</pub-id>
</element-citation>
</ref>
<ref id="R60">
<label>60</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Easton</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Lourdusamy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Havranek</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mizuno</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Solati</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Golub</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>alphaCaMKII controls the establishment of cocaine’s reinforcing effects in mice and humans</article-title>
<source/>Transl Psychiatry
          <year>2014</year>
<volume>4</volume>
<fpage>e457</fpage>
<pub-id pub-id-type="pmid">25290264</pub-id>
</element-citation>
</ref>
<ref id="R61">
<label>61</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferrario</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Loweth</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Milovanovic</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ford</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Galinanes</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Heng</surname>
<given-names>LJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Alterations in AMPA receptor subunits and TARPs in the rat nucleus accumbens related to the formation of Ca(2)(+)-permeable AMPA receptors during the incubation of cocaine craving</article-title>
<source/>Neuropharmacology
          <year>2011</year>
<volume>61</volume>
<issue>7</issue>
<fpage>1141</fpage>
<lpage>1151</lpage>
<pub-id pub-id-type="pmid">21276808</pub-id>
</element-citation>
</ref>
<ref id="R62">
<label>62</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Araki</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ago</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hasebe</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nishiyama</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Oka</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Involvement of prefrontal AMPA receptors in encounter stimulation-induced hyperactivity in isolation-reared mice</article-title>
<source/>Int J Neuropsychopharmacol
          <year>2014</year>
<volume>17</volume>
<issue>6</issue>
<fpage>883</fpage>
<lpage>893</lpage>
<pub-id pub-id-type="pmid">24405605</pub-id>
</element-citation>
</ref>
<ref id="R63">
<label>63</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neuhofer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Henstridge</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Dudok</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sepers</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lassalle</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Katona</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Functional and structural deficits at accumbens synapses in a mouse model of Fragile X</article-title>
<source/>Front Cell Neurosci
          <year>2015</year>
<volume>9</volume>
<fpage>100</fpage>
<pub-id pub-id-type="pmid">25859182</pub-id>
</element-citation>
</ref>
<ref id="R64">
<label>64</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Badurek</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dileone</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Nashmi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Minichiello</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Picciotto</surname>
<given-names>MR</given-names>
</name>
</person-group>
<article-title>GABAergic and glutamatergic efferents of the mouse ventral tegmental area</article-title>
<source/>J Comp Neurol
          <year>2014</year>
<volume>522</volume>
<issue>14</issue>
<fpage>3308</fpage>
<lpage>3334</lpage>
<pub-id pub-id-type="pmid">24715505</pub-id>
</element-citation>
</ref>
<ref id="R65">
<label>65</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>HK</given-names>
</name>
<name>
<surname>Huganir</surname>
<given-names>RL</given-names>
</name>
</person-group>
<article-title>Interaction of the AMPA receptor subunit GluR2/3 with PDZ domains regulates hippocampal long-term depression</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2001</year>
<volume>98</volume>
<issue>20</issue>
<fpage>11725</fpage>
<lpage>11730</lpage>
<pub-id pub-id-type="pmid">11573007</pub-id>
</element-citation>
</ref>
<ref id="R66">
<label>66</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seidenman</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Steinberg</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Huganir</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Malinow</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Glutamate receptor subunit 2 Serine 880 phosphorylation modulates synaptic transmission and mediates plasticity in CA1 pyramidal cells</article-title>
<source/>J Neurosci
          <year>2003</year>
<volume>23</volume>
<issue>27</issue>
<fpage>9220</fpage>
<lpage>9228</lpage>
<pub-id pub-id-type="pmid">14534256</pub-id>
</element-citation>
</ref>
<ref id="R67">
<label>67</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>States</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Khatri</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ziff</surname>
<given-names>EB</given-names>
</name>
</person-group>
<article-title>Stable synaptic retention of serine-880-phosphorylated GluR2 in hippocampal neurons</article-title>
<source/>Mol Cell Neurosci
          <year>2008</year>
<volume>38</volume>
<issue>2</issue>
<fpage>189</fpage>
<lpage>202</lpage>
<pub-id pub-id-type="pmid">18417360</pub-id>
</element-citation>
</ref>
<ref id="R68">
<label>68</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olson</surname>
<given-names>VG</given-names>
</name>
<name>
<surname>Zabetian</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Bolanos</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Edwards</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Barrot</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Eisch</surname>
<given-names>AJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Regulation of drug reward by cAMP response element-binding protein: evidence for two functionally distinct subregions of the ventral tegmental area</article-title>
<source/>J Neurosci
          <year>2005</year>
<volume>25</volume>
<issue>23</issue>
<fpage>5553</fpage>
<lpage>5562</lpage>
<pub-id pub-id-type="pmid">15944383</pub-id>
</element-citation>
</ref>
<ref id="R69">
<label>69</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghosh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Carnahan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>Requirement for BDNF in activity-dependent survival of cortical neurons</article-title>
<source/>Science
          <year>1994</year>
<volume>263</volume>
<issue>5153</issue>
<fpage>1618</fpage>
<lpage>1623</lpage>
<pub-id pub-id-type="pmid">7907431</pub-id>
</element-citation>
</ref>
<ref id="R70">
<label>70</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Finkbeiner</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Arnold</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Shaywitz</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism</article-title>
<source/>Neuron
          <year>1998</year>
<volume>20</volume>
<issue>4</issue>
<fpage>709</fpage>
<lpage>726</lpage>
<pub-id pub-id-type="pmid">9581763</pub-id>
</element-citation>
</ref>
<ref id="R71">
<label>71</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hong</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>McCord</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>A biological function for the neuronal activity-dependent component of Bdnf transcription in the development of cortical inhibition</article-title>
<source/>Neuron
          <year>2008</year>
<volume>60</volume>
<issue>4</issue>
<fpage>610</fpage>
<lpage>624</lpage>
<pub-id pub-id-type="pmid">19038219</pub-id>
</element-citation>
</ref>
<ref id="R72">
<label>72</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>West</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>WG</given-names>
</name>
<name>
<surname>Dalva</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Dolmetsch</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Kornhauser</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Shaywitz</surname>
<given-names>AJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Calcium regulation of neuronal gene expression</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2001</year>
<volume>98</volume>
<issue>20</issue>
<fpage>11024</fpage>
<lpage>11031</lpage>
<pub-id pub-id-type="pmid">11572963</pub-id>
</element-citation>
</ref>
<ref id="R73">
<label>73</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>Multiple faces of BDNF in cocaine addiction</article-title>
<source/>Behav Brain Res
          <year>2015</year>
<volume>279</volume>
<fpage>240</fpage>
<lpage>254</lpage>
<pub-id pub-id-type="pmid">25449839</pub-id>
</element-citation>
</ref>
<ref id="R74">
<label>74</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wook Koo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Labonte</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Engmann</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Calipari</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Juarez</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lorsch</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Essential Role of Mesolimbic Brain-Derived Neurotrophic Factor in Chronic Social Stress-Induced Depressive Behaviors</article-title>
<source/>Biol Psychiatry
          <year>2015</year>
</element-citation>
</ref>
<ref id="R75">
<label>75</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caldeira</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Melo</surname>
<given-names>CV</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Correia</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Backos</surname>
<given-names>DS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Brain-derived neurotrophic factor regulates the expression and synaptic delivery of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor subunits in hippocampal neurons</article-title>
<source/>J Biol Chem
          <year>2007</year>
<volume>282</volume>
<issue>17</issue>
<fpage>12619</fpage>
<lpage>12628</lpage>
<pub-id pub-id-type="pmid">17337442</pub-id>
</element-citation>
</ref>
<ref id="R76">
<label>76</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reimers</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Loweth</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>BDNF contributes to both rapid and homeostatic alterations in AMPA receptor surface expression in nucleus accumbens medium spiny neurons</article-title>
<source/>Eur J Neurosci
          <year>2014</year>
<volume>39</volume>
<issue>7</issue>
<fpage>1159</fpage>
<lpage>1169</lpage>
<pub-id pub-id-type="pmid">24712995</pub-id>
</element-citation>
</ref>
<ref id="R77">
<label>77</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>Brain-derived neurotrophic factor rapidly increases AMPA receptor surface expression in rat nucleus accumbens</article-title>
<source/>Eur J Neurosci
          <year>2011</year>
<volume>34</volume>
<issue>2</issue>
<fpage>190</fpage>
<lpage>198</lpage>
<pub-id pub-id-type="pmid">21692887</pub-id>
</element-citation>
</ref>
<ref id="R78">
<label>78</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGinty</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Whitfield</surname>
<given-names>TW</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Berglind</surname>
<given-names>WJ</given-names>
</name>
</person-group>
<article-title>Brain-derived neurotrophic factor and cocaine addiction</article-title>
<source/>Brain Res
          <year>2010</year>
<volume>1314</volume>
<fpage>183</fpage>
<lpage>193</lpage>
<pub-id pub-id-type="pmid">19732758</pub-id>
</element-citation>
</ref>
<ref id="R79">
<label>79</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zamponi</surname>
<given-names>GW</given-names>
</name>
</person-group>
<article-title>Targeting voltage-gated calcium channels in neurological and psychiatric diseases</article-title>
<source/>Nat Rev Drug Discov
          <year>2016</year>
<volume>15</volume>
<issue>1</issue>
<fpage>19</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="pmid">26542451</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Pharmacological inhibition and activation of VTA Ca<sub>v</sub>1.3 channels oppositely regulates cocaine behaviors. (<bold>a</bold>) Western blot showing the presence of Ca<sub>v</sub>1.3 protein in VTA PSD fractions from wildtype (WT) and Ca<sub>v</sub>1.3 knockout (KO) mice. (<bold>b</bold>) Schematic of Ca<sub>v</sub>1.3 showing its ITTL in the C-terminal cytoplasmic domain and its interaction with PSD-95 and Shank. (<bold>c</bold>) Western blots showing immunoprecipitated PSD95 and Shank with Ca<sub>v</sub>1.3 antibody in VTA protein lysates. (<bold>d</bold>) Disruption of Ca<sub>v</sub>1.3 PDZ domain ITTL with an inhibitory peptide blocks KCl- (Two-way ANOVA, [Peptide x KCl, F<sub>(1, 20)</sub> = 4.831, <italic>P</italic>=0.0399]; Bonferroni <italic>post hoc</italic>, Control Peptide: Vehicle vs KCl *<italic>P</italic>&lt;0.05, KCl: Control Peptide vs ITTL Peptide <sup>†</sup><italic>P</italic>&lt;0.05) and BayK- (Two-way ANOVA, [Peptide x BayK, F<sub>(1, 20)</sub> = 7.593, <italic>P</italic>=0.0122]; Bonferroni <italic>post hoc</italic> test: Control Peptide: Vehicle vs BayK *<italic>P</italic>&lt;0.05, BayK: Control Peptide vs ITTL Peptide <sup>††</sup><italic>P</italic>&lt;0.01) induced Ser 133 P-CREB phosphorylation in VTA slices from Ca<sub>v</sub>1.2 DHP<sup>−/−</sup> mice. For all groups, n = 6. (<bold>e, f, i, l</bold>) Schematic timeline of behavioral protocol and VTA infusion of either Veh or Nif, Veh or BayK in Ca<sub>v</sub>1.2DHP<sup>−/−</sup> mice, or Ca<sub>v</sub>1.3 shRNA in C57BL/6 mice. (<bold>g-h</bold>) Intra<bold>-</bold>VTA microinjection of Nif in Ca<sub>v</sub>1.2 DHP<sup>−/−</sup> mice administered prior to each cocaine conditioning session attenuated (<bold>g</bold>) expression of CPP on Day 5 (WD1) and Day 34 (WD30) (Two-way ANOVA, [VTA infusion x day, F<sub>(2,60)</sub> = 7.595, <italic>P</italic>=0.0011]; Bonferroni <italic>post hoc</italic> test: Veh: Day 1 vs Day 5 ***<italic>P</italic>&lt;0.001, Veh: Day 1 vs Day 34 ***<italic>P</italic>&lt;0.001, Day 5: Veh vs Nif <sup>††</sup><italic>P</italic>&lt;0.01, Day 34: Veh vs Nif <sup>†††</sup><italic>P</italic>&lt;0.001. Veh n = 12, Nif n = 10), and (<bold>h)</bold> the cocaine-induced locomotor activity measured on day 36 (t<sub>(17)</sub> = 2.86, *<italic>P</italic>=0.0108. Veh n = 10, Nif n = 9). (<bold>i</bold>) Inset, image shows green fluorescent protein (GFP-green), tyrosine hydroxylase (TH-red) and dual-labeled (yellow) cells. (<bold>j, k</bold>) Intra-VTA stereotaxic delivery of Ca<sub>v</sub>1.3 shRNA (21 days before the start of CPP) attenuated (<bold>j</bold>) the expression of CPP tested on day 5 and 34 (Two-Way ANOVA, [VTA injection x day, F<sub>(2,51)</sub> = 14.09, <italic>P</italic>&lt; 0.0011]; Bonferroni <italic>post hoc</italic> test: Ctrl shRNA: Day 1 vs Day 5 ***<italic>P</italic>&lt;0.001, Ctrl shRNA Day 1 vs Day 34 ***<italic>P</italic>&lt;0.001, Day 5: Ctrl shRNA vs Ca<sub>v</sub>1.3 shRNA <sup>††</sup><italic>P</italic>&lt;0.01, Day 34: Ctrl shRNA vs Ca<sub>v</sub>1.3 shRNA <sup>†††</sup><italic>P</italic>&lt;0.001. Ctrl shRNA n= 10, Ca<sub>v</sub>1.3 shRNA n = 9), and <bold>(k)</bold> cocaine-induced locomotor activity measured on day 36 (<italic>t</italic>-test, t<sub>(17)</sub> = 3.066, **<italic>P</italic>=0.0070. Ctrl shRNA n = 10, Ca<sub>v</sub>1.3 shRNA n = 9). (<bold>m, n</bold>) Intra-VTA infusion of BayK prior to each cocaine conditioning session enhanced (<bold>m</bold>) expression of cocaine CPP on day 5 and 34 (Two-way ANOVA, [VTA infusion x day F<sub>(2,48)</sub> = 3.206, <italic>P</italic>=0.0493]; Bonferroni <italic>post hoc</italic> test: Veh: Day 1 vs Day 5 ***<italic>P</italic>&lt;0.001, Veh: Day 1 vs Day 34 **<italic>P</italic>&lt;0.01, Day 5: Veh vs BayK <sup>†</sup><italic>P</italic>&lt;0.05, Day 34: Veh vs BayK <sup>†</sup><italic>P</italic>&lt;0.05. Veh n = 9, BayK n = 9), and (<bold>n</bold>) enhanced cocaine-induced locomotor response on day 36 (t<sub>(16)</sub> = 3.955, **<italic>P</italic>=0.0011. Veh n = 9, BayK n = 9). Error bars represent ± s.e.m.</p>
</caption>
<graphic xlink:href="nihms839087f1"></graphic>
</fig>
<fig id="F2" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<p>VTA Ca<sub>v</sub>1.3 channels mediate long-term increase in CP-AMPARs at the NAc PSD of cocaine-exposed mice. (<bold>a</bold>) Schematic representation of VTA projection to the NAc and PFC. (<bold>b</bold>) Cocaine administration increased GluA1 but not GluA2 protein levels at the NAc PSD at WD30 that was blocked by Nif pretreatment (GluA1: Two-way ANOVA, [pre-treatment x post-treatment, F<sub>(1,22)</sub> = 18.82, <italic>P</italic>&lt; 0.0003]. Bonferroni <italic>post hoc</italic> test: Veh-Sal vs Veh-coc ***<italic>P</italic>&lt;0.001, Veh-coc vs Nif-coc <sup>†††</sup><italic>P</italic>&lt;0.001; Veh-Sal n = 7, Nif-Sal n = 5, Veh-Coc n = 7, Nif-Coc n = 8). (<bold>c</bold>) No difference in GluA1 or GluA2 levels was seen in the PFC PSD (Veh-Sal n = 7, Nif-Sal, n = 5, Veh-Coc, n = 7, Nif-Coc, n = 8). ***<italic>P</italic> &lt;0.0001, †††<italic>P</italic> &lt; 0.001. (<bold>d</bold>) Experimental timeline of Naspm microinjection. (<bold>e</bold>) Schematic of Naspm infusion in the NAc shell. (<bold>f-g</bold>) Naspm infusion in the NAc shell prior to (<bold>f</bold>) cocaine CPP test on day 34 attenuated expression of cocaine CPP (Day 1 and 5, Two-way ANOVA, [day, F<sub>(1,36)</sub> = 51.05, <italic>P</italic>&lt;0.001]; Bonferroni <italic>post hoc</italic> test: Veh and Naspm groups: Day 5 vs Day 1 ***<italic>P</italic>&lt;0.001; Day 34, <italic>t</italic>-test, t<sub>(18)</sub>=2.881, <sup>††</sup><italic>P</italic>=0.0099. Veh n = 8, Naspm n = 12) and (<bold>g</bold>) cocaine-induced locomotor activity test on day 34 attenuated expression of psychomotor sensitization (Day 1 and 5, Two-way ANOVA, [day, F<sub>(1,28)</sub> = 23.76, <italic>P</italic>&lt;0.001]; Bonferroni <italic>post hoc</italic> test: Veh group: Day 5 vs Day 1 **<italic>P</italic>&lt;0.01, Naspm group: Day 1 vs. Day 5 *<italic>P</italic>&lt;0.05; Day 34, <italic>t-</italic>test, t<sub>(14)</sub>= 2.767, <sup>†</sup><italic>P</italic>=0.0151. Veh n = 8, Naspm n = 12). (<bold>h</bold>) VTA Nif pretreatment in Ca<sub>v</sub>1.2DHP<sup>−/−</sup> mice blocked cocaine-induced increase in CaMKIIα, P-T286 CaMKIIα and P-S831 GluA1 in the NAc of cocaine exposed mice examined 30 days later (Two-way ANOVA, [CaMKIIα: pretreatment x posttreatment, F<sub>(1,23)</sub> = 9.091, <italic>P</italic>=0.0062]; Bonferroni <italic>post hoc</italic> test: Veh-Sal vs Veh-Coc ***<italic>P</italic>&lt;0.001, Veh-Coc vs Nif-Coc <sup>†††</sup><italic>P</italic>&lt;0.001; [P-T286 CaMKIIα: F<sub>(1,23)</sub> = 13.11, <italic>P</italic>=0.0014]; Veh-Sal vs Veh-Coc ***<italic>P</italic>&lt;0.001, Veh-Coc vs Nif-Coc <sup>†††</sup><italic>P</italic>&lt;0.001; [P-S831 GluA1: F<sub>(1,23)</sub> = 4.247, <italic>P</italic>=0.05]; Veh-Sal vs Veh-Coc ***<italic>P</italic>&lt;0.001, Veh-Coc vs Nif-Coc <sup>††</sup><italic>P</italic>&lt;0.01. Veh-Sal n = 7, Nif-Sal n = 6, Veh-Coc n = 7, Nif-Coc n = 7). <bold>(i)</bold> S831A GluA1 phospho-mutant mice presented a blunted cocaine CPP response (Two-Way ANOVA, [day x genotype, F<sub>(2,50)</sub> = 3.211, <italic>P</italic>=0.0488]; Bonferroni <italic>post hoc</italic> test: WT and S831A: Day1 vs Day 5 ***<italic>P</italic>&lt;0.001, WT: Day1 vs Day 34 ***<italic>P</italic>&lt;0.001, Day 34: WT vs. S831A <sup>†</sup><italic>P</italic>&lt;0.05. WT n = 10, S831A n = 9), and (<bold>j</bold>) blunted cocaine-induced locomotor activity on Day 34 (Two-Way ANOVA, [day x genotype, F<sub>(2,48)</sub> = 8.863, <italic>P</italic>=0.0005]; Bonferroni <italic>post hoc</italic> test: WT: Day1 vs Day 5 **<italic>P</italic>&lt;0.01, S831A: Day1 vs Day 5 ***<italic>P</italic>&lt;0.001, WT: Day 1 vs Day 34 ***P&lt;0.001, Day 34: WT vs S831A <sup>†</sup><italic>P</italic>&lt;0.05. WT n = 8, S831A n = 10). Error bars represent ± s.e.m.</p>
</caption>
<graphic xlink:href="nihms839087f2"></graphic>
</fig>
<fig id="F3" orientation="portrait" position="float">
<label>Figure 3</label>
<caption>
<p>Repeated VTA BayK 8644 treatment results in depressive-like behavior, social interaction deficits and enhanced cocaine psychomotor activity. (<bold>a</bold>) Experimental timeline of VTA-BayK infusion and behavioral testing. (<bold>b–d</bold>) Repeated administration of BayK in the VTA decreased sucrose preference (<bold>b</bold>, t<sub>(18)</sub> = 3.486, **<italic>P</italic>=0.0026. Veh n = 10, BayK n = 10), increased immobility time in FST (<bold>c,</bold> t<sub>(12)</sub> = 2.725, *<italic>P</italic>=0.0184. Veh n = 7, BayK n = 7), and impaired social approach behavior (<bold>d,</bold> Two-Way ANOVA, [genotype x contact zone, F<sub>(1,36)</sub> = 13.56, <italic>P</italic>=0.0008]; Veh: stranger vs empty cup **<italic>P</italic>&lt;0.01. Veh n = 10, BayK n = 10). (<bold>e</bold>) BayK administration in the VTA increased GluA1 and GluA2 protein in the NAc PSD when tested 30 days later (GluA1: t<sub>(17)</sub> = 3.247, **<italic>P</italic>=0.0047. Veh n = 9, BayK: n = 10; GluA2: t<sub>(17)</sub> = 2.366, *<italic>P</italic>=0.0301. Veh n = 9, BayK n = 10). (<bold>f</bold>) Experimental timeline. (<bold>g–i</bold>) Naspm infusion in the NAc shell prior to (<bold>g)</bold> SPT (Two-Way ANOVA, [pre-treatment (Veh or BayK): F<sub>(1,34)</sub> = 6.351, <italic>P</italic>=0.016]; Bonferroni <italic>post hoc</italic> test: Veh-Veh vs. BayK-Veh **<italic>P</italic>=0.0079. Veh-Veh n = 8, Veh-Naspm, n = 9, BayK-Veh n = 10, BayK-Naspm n = 11) or (<bold>h)</bold> FST (Two-Way ANOVA, [pretreatment x posttreatment, F<sub>(1,34)</sub> = 4.903, <italic>P</italic>=0.0336]; Bonferroni <italic>post hoc</italic> test: Veh-Veh vs BayK-Veh *<italic>P</italic>&lt;0.05, BayK-Veh vs BayK-Naspm <sup>†</sup><italic>P</italic>&lt;0.05. Veh-Veh n = 8, Veh-Naspm n = 9, BayK-Veh n = 10, BayK-Naspm n = 11), rescued depressive-like behavior and (<bold>i</bold>) decreased the enhanced cocaine-induced locomotor response (Two-Way ANOVA, [pre-treatment (Veh or BayK): F<sub>(1,34)</sub> = 19.96, <italic>P</italic>&lt;0.0001]; post-treatment (Veh or Naspm): F<sub>(1,34)</sub> = 6.117, <italic>P</italic>=0.0185]; Bonferroni <italic>post hoc</italic> test: Veh-Veh vs BayK-Veh ***<italic>P</italic>&lt;0.001, BayK-Veh vs BayK-Naspm <sup>†</sup><italic>P</italic>&lt;0.05. Veh-Veh n = 8, Veh-Naspm n = 9, BayK-Veh n = 10, BayK-Naspm n = 11), observed in BayK treated mice. (<bold>j–m</bold>) Naspm infusion in the (<bold>j</bold>) NAc shell (Two-way ANOVA, [pre-treatment (Veh or BayK): F<sub>(1,34)</sub> = 16.83, <italic>P</italic>&lt; 0.0002]; Bonferroni <italic>post hoc</italic> test: Veh-Veh vs BayK-Veh **<italic>P</italic>&lt;0.01, Veh-Naspm vs BayK-Naspm *<italic>P</italic>&lt;0.05. Veh-Veh n = 9; Veh-Naspm n = 9, BayK-Veh n = 10, BayK-Naspm n = 10)<bold>,</bold> or (<bold>k</bold>) in the NAc core (Two-way ANOVA, [pre-treatment (Veh or BayK): F<sub>(1,32)</sub> = 11.67, <italic>P</italic>&lt; 0.0017]; Bonferroni <italic>post hoc</italic> test: Veh-Veh vs BayK-Veh *<italic>P</italic>&lt;0.05, Veh-Naspm vs BayK-Naspm <italic>P</italic>=0.0526. Veh-Veh n = 8, Veh-Naspm n = 8, BayK-Veh n = 10, BayK-Naspm n = 10) had no effect on BayK-induced social approach deficit, whereas NBQX infusion in (<bold>l</bold>) the NAc core (Two-Way ANOVA, [pretreatment x posttreatment, F <sub>(1,35)</sub> = 5.403, <italic>P</italic>=0.0260]; Bonferroni <italic>post hoc</italic> test: Veh-Veh vs BayK-Veh *<italic>P</italic>&lt;0.01, BayK-Veh vs BayK-NBQX <sup>†</sup><italic>P</italic>&lt;0.05. Veh-Veh n = 9, Veh-NBQX n = 9, BayK-Veh n = 10, BayK-NBQX n = 11), but not in (<bold>m</bold>) the NAc shell [pre-treatment (BayK or Veh), F<sub>(1,28)</sub> = 15.74, <italic>P</italic>=0.0005]; Post-treatment (NBQX or Veh), F<sub>(1,28)</sub> = 0.1436, <italic>P</italic> = 0.7076]; Bonferroni <italic>post hoc</italic> test: Veh-Veh vs BayK-Veh *<italic>P</italic>&lt;0.05. Veh-NBQX vs BayK-NBQX <italic>P</italic>=0.0829. Veh-Veh n = 8, Veh-NBQX n = 8, BayK-Veh n = 8, BayK-NBQX n = 8), rescued the BayK- induced social approach deficit. Error bars represent ± s.e.m.</p>
</caption>
<graphic xlink:href="nihms839087f3"></graphic>
</fig>
<fig id="F4" orientation="portrait" position="float">
<label>Figure 4</label>
<caption>
<p>Repeated BayK-induced depressive-like and cocaine behavior is dependent on phosphorylation of GluA1 at S831. (<bold>a</bold>) Repeated BayK infusion in the VTA increased CaMKIIα and P-S831 GluA1 phosphorylation in the NAc examined 30 days later (CaMKIIα: t<sub>(12)</sub> = 2.589, *<italic>P</italic>=0.0237; P-T286 CaMKIIα: t<sub>(12)</sub> = 2.132, <italic>P</italic>=0.0543; P-831 GluA1: t<sub>(12)</sub> = 2.378, *<italic>P</italic>=0.0349. VTA-Veh n = 7, VTA-BayK n = 7). (<bold>b, c</bold>) Repeated BayK infusion in the VTA of WT mice but not S831A mice resulted in depressive-like behavior as revealed in (<bold>b</bold>) the SPT (Two-Way ANOVA, [genotype x pretreatment, F<sub>(1,32)</sub> = 4.983, <italic>P</italic>=0.0327]; Bonferroni <italic>post hoc</italic> test: WT: Veh vs BayK *<italic>P</italic>&lt;0.05, BayK: WT vs S831A <sup>†</sup><italic>P</italic>&lt;0.05. WT-Veh n = 9, WT-BayK n = 10, S831A-Veh n = 8, S831A-BayK n = 9) and (<bold>c</bold>) FST (Two-Way ANOVA, [genotype x pretreatment, F<sub>(1,32)</sub> = 6.145, <italic>P</italic>=0.0186]; Bonferroni <italic>post hoc</italic> test: WT:Veh vs BayK *<italic>P</italic>&lt;0.05, BayK:WT vs S831A Mut <sup>†</sup><italic>P</italic>&lt;0.05. WT-Veh n = 9, WT-BayK n = 10, S831A-Veh n = 8, S831A-BayK n = 9). (<bold>d</bold>) Repeated BayK infusion in the VTA of WT and S831A mutant mice induced social approach deficits in both genotypes (Two way ANOVA, [pretreatment, F<sub>(1,32)</sub> = 14.10, <italic>P=</italic>0.0007]; Bonferroni <italic>post hoc</italic> test: WT: Veh vs BayK *<italic>P</italic>&lt;0.05, S831A: Veh vs BayK *<italic>P</italic>&lt;0.05. WT-Veh n = 9, WT-BayK n = 10, S831A-Veh: n = 8, S831A-BayK n = 9). (<bold>e</bold>) Repeated BayK treatment in the VTA resulted in higher cocaine-induced locomotor activity in WT but not S831A mutant mice (Two-Way ANOVA, [genotype F<sub>(1,32)</sub> = 13.58, <italic>P=</italic>0.0008], Bonferroni <italic>post hoc</italic> test: WT: Veh vs BayK **<italic>P</italic>&lt;0.01. WT-Veh n = 9, WT-BayK n = 10, S831A-Veh n = 8, S831A-BayK n = 9). Error bars represent ± s.e.m.</p>
</caption>
<graphic xlink:href="nihms839087f4"></graphic>
</fig>
<fig id="F5" orientation="portrait" position="float">
<label>Figure 5</label>
<caption>
<p>Regional association plot of SNPs in and around <italic>CACNA1D</italic>. (<bold>a</bold>) SNPs are plotted with their −log10 (p-value) on the y-axis along with their physical position (NCBI build 36) on the x-axis. The SNPs are color coded according to their correlations (r<sup>2</sup>) with the most significant SNP rs4687735 shown in purple. The light blue line and right y-axis indicates the observed recombination rates in the HapMap CEU samples.</p>
</caption>
<graphic xlink:href="nihms839087f5"></graphic>
</fig>
</floats-group>
</article>
</pmc-articleset>